{"gene":"BRF1","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":1994,"finding":"Yeast BRF (BRF1 ortholog) binds the 135-kD subunit of TFIIIC and also binds TBP; TBP interacts with both the TFIIB-homologous N-terminal half and the C-terminal half of BRF, with two conserved C-terminal regions required for the TBP–BRF C-terminal interaction. BRF also binds RNA Pol III subunit C34, and a region of C34 necessary for this interaction was defined.","method":"Protein–protein interaction assays (binding assays between BRF fragments and TFIIIC subunit, TBP, and Pol III subunit C34); functional analysis of deletion mutants; TBP mutants that selectively inhibit Pol III transcription in vivo impair the BRF C-terminal–TBP interaction","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal binding assays with deletion mutants and TBP point mutants, replicated across yeast species","pmids":["7995525"],"is_preprint":false},{"year":1996,"finding":"Human BRF1 (TFIIIB90/hBRF, 88 kDa) was purified as a TBP-associated complex and identified as the human homolog of yeast BRF. Immunodepletion of hBRF severely debilitates transcription from the tRNA-type VAI promoter but does not affect transcription from the TATA box-containing human U6 promoter, indicating promoter-type-specific requirement for hBRF.","method":"Biochemical purification; cDNA cloning; immunodepletion of hBRF from transcription extracts followed by in vitro transcription from VAI and U6 promoters","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro transcription reconstitution with immunodepletion, two distinct promoter types tested","pmids":["8943358"],"is_preprint":false},{"year":1996,"finding":"Yeast TFIIIB90 (Bdp1/B\") interacts weakly with TBP alone but this interaction is enhanced at least 25-fold by BRF1. TFIIIB was reconstituted from recombinant subunits (TBP, BRF1, TFIIIB90). Binding sites for BRF1 and TFIIIB90 on TBP-DNA overlap with binding sites for TFIIA and TFIIB, indicating shared TBP interface.","method":"Recombinant protein reconstitution; in vitro binding assays; competition with Pol II factors TFIIA and TFIIB","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution from recombinant subunits with quantitative binding measurements, multiple orthogonal assays","pmids":["8662956"],"is_preprint":false},{"year":1997,"finding":"N-terminal deletion analysis of yeast Brf1 showed that the C-terminal half (residues 317–596) lacking the entire TFIIB-homologous domain can still interact with DNA-bound TBP and with B\"/Bdp1. Brf1(165–596) lacking 164 N-proximal TFIIB-homologous residues is competent for TFIIIB-DNA complex assembly and TFIIIC-independent transcription, revealing functional complementarity and reciprocity between Brf1 and B\" subunits.","method":"N-terminal deletion series of Brf1 tested in TFIIIB-DNA complex assembly and in vitro transcription; genetic complementation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic deletion mutagenesis combined with in vitro transcription reconstitution","pmids":["9271407"],"is_preprint":false},{"year":1998,"finding":"TBP surface residues on the top and side of the first TBP repeat (K181, L185, R186, E206, R231, L232, R235, K236, R239, Q242, K243, K249, F250) are required for interaction with yeast Pol III TAF Brf. The Brf C-terminal fragment (lacking TFIIB-homology region) retains TBP-DNA binding via this same surface. Brf and TFIIB interact differently with TBP; the Brf-binding surface on TBP overlaps with surfaces required for activated Pol II transcription.","method":"91 human TBP surface mutants analyzed in gel-shift assays with purified Brf and B\"; in vitro U6 snRNA transcription; equivalent yeast TBP mutations tested","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis of 91 TBP residues with both binding and transcription functional readouts","pmids":["9488486"],"is_preprint":false},{"year":1998,"finding":"Systematic analysis of Brf fragments defined that the principal TFIIIB-assembly function maps to a C-proximal segment (aa 435–545), while the principal transcription-directing function resides in the N-proximal TFIIB-homologous half. Split Brf fragments (aa 1–282 + 284–596) reconstitute fully active TFIIIB-DNA complexes. Photochemical cross-linking mapped proximities of each Brf half to DNA, providing a global model of Brf domain organization in the TFIIIB-DNA complex.","method":"Systematic Brf fragment analysis; in vitro transcription reconstitution; in vitro footprinting; photochemical protein-DNA cross-linking; TBP interaction mapping","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — extensive fragment library tested with multiple orthogonal methods (transcription, footprinting, cross-linking)","pmids":["9710642"],"is_preprint":false},{"year":2000,"finding":"In Drosophila, TRF1 (rather than TBP) forms a complex with BRF to direct RNA polymerase III transcription. Immunoprecipitation showed TRF1:BRF complex in vivo; immunodepleted extracts supplemented with recombinant TRF1 and BRF reconstitute transcription of tRNA, 5S, and U6 RNA genes. In vivo, the majority of TRF1 is complexed with BRF and the two proteins colocalize at many polytene chromosome sites containing RNA Pol III genes.","method":"Immunoprecipitation; immunodepletion followed by in vitro transcription reconstitution with recombinant proteins; immunofluorescence colocalization on polytene chromosomes","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution from recombinant proteins combined with in vivo colocalization, multiple orthogonal methods","pmids":["10850489"],"is_preprint":false},{"year":2000,"finding":"Recombinant Brf and TBP subunits of TFIIIB, interacting over the SNR6 TATA box, are sufficient to direct Ty3 retrotransposon integration at the SNR6 transcription initiation site in the absence of detectable TFIIIC or TFIIIB subunit B\", establishing that the minimal requirements for Pol III transcription and Ty3 integration are very similar.","method":"In vitro integration assay with recombinant Brf and TBP; TFIIIC-independent system using U6/SNR6 gene with TATA box","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with defined recombinant proteins, clear functional readout","pmids":["10882723"],"is_preprint":false},{"year":2000,"finding":"Alternatively spliced human BRF variants have distinct promoter specificities: hBRF1 functions at the gene-internal 5S, VA1, 7SL and EBER2 promoters, while a different variant hBRF2 is required at the gene-external human U6 promoter, demonstrating that Pol III utilizes different TFIIIB complexes at structurally distinct promoters.","method":"Isolation of alternatively spliced cDNAs; immunopurification of hBRF-containing complexes; in vitro transcription from different Pol III promoter types","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution with purified isoform-containing complexes and multiple promoter types tested","pmids":["10921893"],"is_preprint":false},{"year":2001,"finding":"In human cells, a TFIIIB subcomponent containing TBP and TAF3B2 (human BRF1) is the target of repression during p53-mediated cell cycle arrest. TAF3B2 protein levels are markedly reduced in extracts from cell cycle-arrested cells due to decreased TAF3B2 protein stability, providing a mechanism for reducing Pol III transcriptional capacity.","method":"Cell-based complementation assays with in vitro transcription; protein stability analysis in p53-arrested cells; cell fractionation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complementation assays plus protein stability measurement, single lab with two orthogonal methods","pmids":["11283026"],"is_preprint":false},{"year":2002,"finding":"BRF1 (butyrate response factor 1, ZFP36L1 family) was identified as an essential regulator of ARE-dependent mRNA decay: a mutagenized cell line (slowC) failing to degrade ARE-containing mRNA carries frameshift mutations in both BRF1 alleles; retroviral re-expression rescues rapid mRNA decay. siRNA knockdown independently confirms BRF1's active role. BRF1 accelerates mRNA decay and antagonizes PI3-kinase-mediated stabilization; zinc finger mutations abolish both ARE binding and mRNA decay activity.","method":"Functional genetic screen (retroviral cDNA library rescue of decay-deficient cells); flow cytometry-based reporter assay; siRNA knockdown; transfection of BRF1 zinc finger mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue (biallelic mutations identified and complemented) plus independent siRNA validation plus mutagenesis, multiple orthogonal methods","pmids":["12198173"],"is_preprint":false},{"year":2002,"finding":"A gain-of-function mutation (PCF1-1, H190Y) in TPR2 of TFIIIC131 increases binding affinity of TFIIIC131 for Brf1 without affecting Bdp1 binding affinity, by overcoming autoinhibition of Brf1 binding—Brf1 does not interact directly at the mutation site, but the mutation stabilizes an alternative conformation of TFIIIC131 that promotes Brf1 interaction.","method":"Site-directed mutagenesis; structural modeling; binding affinity assays for Brf1 and Bdp1 with TFIIIC131 fragments; dominant mutation analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding assays with domain fragments and mutagenesis, single lab","pmids":["12167707"],"is_preprint":false},{"year":2003,"finding":"The Brf1 and Bdp1 subunits of TFIIIB bind to overlapping sites in the tetratricopeptide repeats (TPRs) of Tfc4 (TFIIIC subunit). TPRs6–9 contain a binding site for Brf1; the L469K mutation in TPR7 reduces Brf1 recruitment into TFIIIB-TFIIIC-DNA complexes and reduces direct Tfc4–Brf1 interaction, and also decreases Bdp1 incorporation, indicating both subunits compete for overlapping Tfc4 sites.","method":"Site-directed mutagenesis of Tfc4 TPR residues; biochemical assembly assays for TFIIIB-TFIIIC-DNA complexes; direct binding assays; multicopy suppression analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutagenesis combined with multiple biochemical binding and assembly assays, multicopy suppression genetics","pmids":["12930823"],"is_preprint":false},{"year":2004,"finding":"Protein kinase B (PKB/Akt) phosphorylates BRF1 (ARE-decay factor) at serine 92 (S92), which impairs BRF1 mRNA decay activity without affecting ARE binding, and induces complex formation of BRF1 with the scaffold protein 14-3-3, causing ARE-mRNA stabilization.","method":"Recombinant BRF1 in vitro mRNA decay assay; in vitro PKB kinase assay; phosphorylation-site mutagenesis (S92A); co-immunoprecipitation of BRF1 with 14-3-3; ARE-mRNA stability measurements in vivo","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstituted decay assay plus kinase assay plus mutagenesis plus co-IP, multiple orthogonal methods in one study","pmids":["15538381"],"is_preprint":false},{"year":2004,"finding":"Brf1 (yeast) induces dissociation of TBP dimers, requiring both its high-affinity TBP-binding C-terminal domain and its TFIIB homology domain working in concert; the C-terminal TBP-binding domain alone is insufficient to promote TBP dimer dissociation.","method":"In vitro TBP dimerization and dissociation assays with Brf1 domain fragments; functional domain analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical assay with domain dissection, single lab","pmids":["15190063"],"is_preprint":false},{"year":2005,"finding":"TTP and BRF-1 (ARE-decay factors) each contain two activation domains that recruit mRNA decay enzymes involved in deadenylation, decapping, 3'-to-5' exonucleolytic decay, and 5'-to-3' exonucleolytic decay. The N-terminal activation domain of BRF-1 functions as a binding platform for mRNA decay enzymes. Both activation domains can activate mRNA decay when fused to a heterologous RNA-binding protein and inhibit ARE-mediated mRNA decay when overexpressed.","method":"Co-immunoprecipitation of mRNA decay enzymes with TTP/BRF-1; tethering assays (fusion to heterologous RNA-binding protein); dominant-negative overexpression; two activation domain mapping","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP with multiple decay enzymes, functional tethering assays, domain mapping, replicated for both TTP and BRF-1","pmids":["15687258"],"is_preprint":false},{"year":2005,"finding":"A Brf1-TBP triple fusion protein (TBP core placed between N- and C-proximal domains of Brf1) effectively replaces both Brf1 and TBP in TFIIIC-dependent and -independent transcription in vitro, forms extremely stable TFIIIB-DNA complexes, and can recruit Pol III for TATA box-directed transcription in the absence of Bdp1, confirming the modular architecture of Brf1 and its bipartite TBP interaction mode.","method":"Structure-informed protein engineering (triple fusion); in vitro transcription reconstitution; chemical nuclease footprinting; in vivo complementation in yeast","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with engineered fusion protein, in vitro and in vivo validation, footprinting","pmids":["16227432"],"is_preprint":false},{"year":2006,"finding":"PKB phosphorylates BRF1 (ARE-decay factor) at a second regulatory site, S203, which cooperates with S92 in vivo. Double alanine mutation of both S92 and S203 uncouples BRF1 from PKB regulation, leading to constitutive mRNA decay. Phosphorylation-dependent 14-3-3 binding requires phosphorylation at both sites. BRF1 is subject to proteasomal degradation (half-life <3 h) but phosphorylation stabilizes it; cell compartment fractionation showed that 14-3-3 binding sequesters BRF1 through relocalization, preventing mRNA decay activity and protecting from proteasomal degradation.","method":"In vitro kinase assay; site-directed mutagenesis (S92A, S203A, double mutant); mRNA decay assays; co-immunoprecipitation with 14-3-3; protein stability assays in PKBα−/− cells; cell fractionation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (kinase assay, mutagenesis, stability assays, fractionation, KO cells), single rigorous study","pmids":["17030608"],"is_preprint":false},{"year":2006,"finding":"The principal attachment site of Brf1 for Bdp1 in TFIIIB was mapped: a 66-amino acid segment of Brf1's C-terminal half serves as a two-sided adhesive surface with one face interacting with TBP and the other anchoring Bdp1. The interacting Bdp1 domain was demarcated to a 66-amino acid segment including the SANT domain, which is the most phylogenetically conserved region of Bdp1.","method":"Structure-informed site-directed mutagenesis; photochemical protein-DNA cross-linking; deletion series of Brf1 and Bdp1 fragments in binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic mutagenesis plus photochemical cross-linking, multiple deletion constructs mapped","pmids":["16551611"],"is_preprint":false},{"year":2006,"finding":"Brf1 peptides from three distinct regions interact with the TPR-containing Tfc4 subunit of TFIIIC. A peptide binding specifically to TPR6-9 of Tfc4 promotes formation of TFIIIC-DNA and Brf1-TFIIIC-DNA complexes and causes a conformational change in TFIIIC that overcomes Tfc4 autoinhibition of Brf1 binding, suggesting repositioning of Brf1 is required during TFIIIB assembly.","method":"Yeast two-hybrid screen of Brf1 peptide libraries against Tfc4 fragments; native gel mobility shift assays; biochemical binding studies","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two-hybrid plus native gel assays, single lab with two orthogonal methods","pmids":["16880507"],"is_preprint":false},{"year":2006,"finding":"In Drosophila, genome-wide ChIP analysis identified 354 TRF1-binding sites, ~78% of which colocalize with BRF. The TRF1/BRF complex is functionally required for transcription of novel targets including 7SL RNA and small nucleolar RNAs, indicating TRF1/BRF is responsible for all known classes of Pol III transcription in Drosophila.","method":"Genome-wide ChIP with tiling microarrays; functional transcription assays for novel targets","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP plus functional transcription assays, single lab","pmids":["17170711"],"is_preprint":false},{"year":2007,"finding":"Human Maf1 represses RNA Pol III transcription via direct interaction with TFIIIB, specifically through the TFIIB family members Brf1 and Brf2 (not through other components). This was demonstrated in vivo with a Pol III luciferase reporter assay.","method":"RNA Pol III luciferase reporter assay in vivo; epistasis analysis showing Maf1 repression acts through Brf1 and Brf2 subunits of TFIIIB","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo reporter assay with epistasis, single lab, pathway placement established","pmids":["17505538"],"is_preprint":false},{"year":2007,"finding":"TTP and BRF-1 (ARE-binding proteins) deliver ARE-mRNAs to processing bodies (PBs). Depletion of endogenous TTP and BRF proteins or dominant-negative TTP impairs ARE-mRNA localization to PBs. TTP and BRF-1 can tether mRNAs to PBs and TTP can nucleate PB formation on untranslated mRNAs. ARE-mRNA PB localization is mediated by TTP N- and C-terminal domains and occurs downstream from polysome release.","method":"siRNA depletion of TTP and BRF proteins; dominant-negative overexpression; tethering assays; fluorescence microscopy/live imaging of reporter ARE-mRNAs in PBs; cycloheximide treatment to trap polysomes","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (depletion, dominant-negative, tethering, live imaging), pathway positioning established","pmids":["17369404"],"is_preprint":false},{"year":2008,"finding":"MAPK-activated protein kinase 2 (MK2) phosphorylates BRF1 (ARE-decay factor) at S54, S92, S203, and an unidentified C-terminal site, inhibiting BRF1's ARE mRNA decay activity. MK2-mediated inhibition requires phosphorylation at S54, S92, and S203. Phosphorylation by MK2 does not alter BRF1's ability to bind AREs or associate with mRNA decay enzymes, suggesting inhibition occurs downstream of RNA binding and decay enzyme recruitment.","method":"In vitro kinase assays with MK2 and BRF1 fragments; site-directed mutagenesis (S54, S92, S203); ARE-mRNA decay assays in cells with active MK2; ARE-binding and co-immunoprecipitation of decay enzymes","journal":"RNA (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional mRNA decay assay plus RNA binding and co-IP, multiple orthogonal methods","pmids":["18326031"],"is_preprint":false},{"year":2008,"finding":"NMR mapping of the Brf1–Bdp1 interaction at single-amino acid resolution showed that the principal anchorage site of Brf1 is on a convex surface of Bdp1 encompassing helix 1 and helix 3 of its conserved SANT domain, with the main Bdp1 anchorage provided by residues 470–495 of Brf1.","method":"NMR chemical shift perturbation mapping using minimal functional segments of Brf1 and Bdp1; NMR-derived structural model","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural mapping at residue resolution with functional segments, single lab","pmids":["19086269"],"is_preprint":false},{"year":2010,"finding":"Ethanol induces RNA Pol III-dependent transcription in HepG2 cells and primary mouse hepatocytes by upregulating BRF1 and TBP expression (TFIIIB components) through JNK1 activation and enhanced c-Jun expression. c-Jun is directly recruited to TBP, BRF1, and tRNA gene promoters. Chronic alcohol administration in mice increases BRF1, TBP, tRNA, and 5S rRNA transcription in liver.","method":"Chromatin immunoprecipitation (ChIP); luciferase reporter assays; siRNA knockdown; in vivo mouse alcohol feeding model; quantitative RT-PCR","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP showing direct c-Jun recruitment to BRF1 promoter, in vitro and in vivo validation, single lab","pmids":["21106530"],"is_preprint":false},{"year":2011,"finding":"Tis11b/BRF1 (ARE-decay factor) binds to endogenous Dll4 mRNA and represses its expression without affecting mRNA stability, through a novel mechanism involving mRNA 3'-end processing. One AUUUA motif in a weak noncanonical polyadenylation signal in the Dll4 3'-UTR is the major Tis11b-binding site. Inhibition of Tis11b expression changes the ratio between mRNAs cleaved or read-through at the poly(A) signal, indicating Tis11b interferes with mRNA cleavage and polyadenylation efficiency.","method":"siRNA knockdown of Tis11b in endothelial cells; RNA immunoprecipitation of endogenous Dll4 mRNA; 3'-UTR reporter assays; poly(A) site usage analysis; hypoxia treatment","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-IP plus functional reporter assays plus poly(A) site analysis, single lab with multiple methods","pmids":["21832157"],"is_preprint":false},{"year":2013,"finding":"Site-specific non-natural amino acid cross-linking mapped Brf1's protein interaction network in the Pol III preinitiation complex: the N-terminal domain of Brf1 shows multiple protein interactions in the Pol III active-site cleft reminiscent of TFIIB, with the cyclin repeat subdomain additionally contacting C34 at its WH2–WH3 connecting region. The C-terminal domain of Brf1 contains extensive binding sites for TBP and Bdp1 to hold TFIIIB together on the promoter.","method":"Site-specific non-natural amino acid incorporation for cross-linking; site-directed hydroxyl radical probing; protein interaction mapping in the preinitiation complex","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-specific cross-linking with non-natural amino acids plus hydroxyl radical probing, comprehensive domain mapping in native PIC","pmids":["24277937"],"is_preprint":false},{"year":2014,"finding":"Brf1 (ZFP36L1/mRNA decay factor) operates downstream of FGF/ERK MAP kinase signaling in mouse embryonic stem cells: ERK signaling upregulates Brf1, which directly destabilizes target mRNAs including Nanog mRNA to disrupt pluripotency-associated gene expression and attenuate mESC self-renewal. Enhanced Brf1 expression preferentially regulates mesendoderm commitment during differentiation, accelerating primitive streak marker expression.","method":"FGF/ERK pathway manipulation; Brf1 gain-of-function and loss-of-function in mESCs; mRNA stability assays for Nanog and other targets; differentiation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis established with gain- and loss-of-function, direct target mRNA destabilization measured, single lab","pmids":["24733888"],"is_preprint":false},{"year":2015,"finding":"Biallelic missense mutations in BRF1 reduce Brf1 occupancy at tRNA target genes in S. cerevisiae, impair yeast cell growth, and reduce Pol III-related transcription activity in vitro. CRISPR-mediated deletion of brf1 in zebrafish recapitulates neurodevelopmental phenotypes. In vivo complementation showed all four candidate disease mutations to be pathogenic in an isoform-specific context, confirming BRF1 mutations that reduce protein activity cause cerebellar hypoplasia and intellectual disability.","method":"Whole-exome sequencing; yeast complementation with human BRF1 disease alleles; ChIP for Brf1 occupancy at tRNA genes in yeast; in vitro Pol III transcription assay; CRISPR deletion and morpholino knockdown in zebrafish","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro transcription assay + ChIP occupancy + in vivo zebrafish complementation + yeast genetics, multiple orthogonal methods","pmids":["25561519"],"is_preprint":false},{"year":2016,"finding":"TIS11b/BRF1 (ARE-decay factor) is phosphorylated by PKA at S54 and S334. Phosphomimetic mutation at C-terminal S334 markedly increases TIS11b half-life and enhances mRNA decay activity; this is accompanied by enhanced interaction with the decapping coactivator Dcp1a. Prevention of phosphorylation at S334 potentiates interaction with the Ccr4-Not deadenylase complex subunit Cnot1, revealing that differential phosphorylation at S334 switches TIS11b's association between distinct decay pathway components.","method":"Site-directed mutagenesis; in vitro kinase assays; phosphosite-specific immunodetection; protein half-life measurements; co-immunoprecipitation with Dcp1a and Cnot1; mRNA decay assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — kinase assay plus mutagenesis plus co-IP with decay machinery components plus functional mRNA decay readout, multiple orthogonal methods","pmids":["27708140"],"is_preprint":false},{"year":2017,"finding":"BRF1 (TFIIIB subunit) physically interacts with estrogen receptor alpha (ERα) in breast cancer cells, as shown by co-immunoprecipitation and colocalization in the nucleus. ERα mediates BRF1 expression, and BRF1 and ERα synergistically regulate transcription of Pol III genes. Inhibition of ERα by siRNA or tamoxifen reduces BRF1 levels and Pol III gene expression.","method":"Co-immunoprecipitation; immunofluorescence colocalization; ChIP; siRNA knockdown of ERα; tamoxifen treatment; Pol III gene expression analysis","journal":"Molecular oncology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP and colocalization with ChIP, single lab, multiple methods but no in vitro reconstitution","pmids":["28972307"],"is_preprint":false},{"year":2018,"finding":"RNF12, a RING domain-containing ubiquitin E3 ligase, physically interacts with BRF1 (TFIIIB subunit) and catalyzes Lys27- and Lys33-linked polyubiquitination of BRF1. RNF12 negatively regulates Pol III-dependent transcription and cell proliferation via BRF1.","method":"Co-immunoprecipitation; in vitro ubiquitination assay; linkage-specific ubiquitin chain analysis; Pol III transcription assays; cell proliferation assays with RNF12 overexpression/knockdown","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro ubiquitination reconstitution plus co-IP plus functional transcription readout, single lab","pmids":["30413534"],"is_preprint":false},{"year":2018,"finding":"The WH3 insertion domain of Rpc82 (TFIIE-related Pol III subunit) interacts with BRF1 within the preinitiation complex, as revealed by site-specific photo-crosslinking. Rpc82 also contacts upstream DNA and the protrusion and wall domains of the Pol III cleft, with the WH3 insertion important for cell growth and in vitro transcription activity.","method":"Site-specific photo-crosslinking with non-natural amino acid; hydroxyl radical probing; in vitro transcription assays; genetic growth assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific cross-linking plus functional assays, single lab","pmids":["29177422"],"is_preprint":false},{"year":2019,"finding":"Brf1 knockout in mice leads to embryonic lethality at the blastocyst stage. Conditional deletion of Brf1 in gastrointestinal epithelial tissues (intestine, liver, pancreas) is incompatible with organ homeostasis and induces apoptosis. Overexpression of BRF1 rescues the phenotypes of Brf1 deletion in intestine and liver, confirming BRF1 is essential for normal tissue homeostasis.","method":"Conditional knockout mouse models; genetic rescue by BRF1 overexpression; histological analysis; apoptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with defined apoptotic phenotype plus genetic rescue, in vivo mammalian model","pmids":["30858608"],"is_preprint":false},{"year":2020,"finding":"Sp1 controls BRF1 expression by binding to the BRF1 promoter 4 (BRF1P4) and promoting occupancy of TBP, TFIIAα, and p300 at this promoter, thereby modulating Pol III gene transcription. Sp1 knockdown inhibits BRF1 expression and Pol III transcription; Sp1 overexpression enhances these activities.","method":"Reporter gene assays; ChIP for Sp1, TBP, TFIIAα, p300 at BRF1 promoter; siRNA knockdown and overexpression of Sp1; Pol III transcription assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus knockdown/OE, single lab with multiple orthogonal methods","pmids":["32115405"],"is_preprint":false}],"current_model":"BRF1 (human TFIIIB90/hBRF, a TFIIB-related factor) is a subunit of RNA Pol III transcription initiation factor TFIIIB that recruits Pol III to promoters by serving as a modular scaffold: its N-terminal TFIIB-homologous domain directs promoter opening and Pol III recruitment while its C-terminal domain provides the primary binding surfaces for TBP (through TBP dimerization dissociation and multi-site interaction), Bdp1 (via a 66-aa Brf1 segment engaging the Bdp1 SANT domain), and TFIIIC subunit Tfc4 (via multiple Brf1 peptide regions subject to Tfc4 autoinhibition); BRF1 is ubiquitinated by RNF12 (Lys27/Lys33-linked) and its protein stability is regulated by PKB-mediated phosphorylation at S92/S203 that promotes 14-3-3 binding and subcellular relocalization. In addition, a separate mammalian BRF1 protein (ZFP36L1/TIS11b, also called BRF-1) is an ARE-binding zinc-finger protein that recruits deadenylation, decapping, and exonucleolytic decay enzymes to ARE-containing mRNAs via two N- and C-terminal activation domains; its activity is negatively regulated by PKB (S92/S203 phosphorylation → 14-3-3 sequestration) and MK2 (S54/S92/S203), and positively or differentially regulated by PKA-mediated phosphorylation at S334, which enhances Dcp1a interaction while reducing Cnot1 interaction; it also delivers ARE-mRNAs to processing bodies downstream of polysome release and operates downstream of FGF/ERK signaling to control pluripotency."},"narrative":{"mechanistic_narrative":"The BRF1 symbol in this corpus maps onto two distinct, internally coherent proteins, and the timeline cleanly separates them. The dominant entity is the RNA Polymerase III transcription factor BRF1 (TFIIIB90/hBRF, a TFIIB-related factor), a subunit of TFIIIB that recruits Pol III to its promoters [PMID:7995525, PMID:8943358]. BRF1 is built as a bipartite, modular scaffold: its N-terminal TFIIB-homologous half carries the principal transcription-directing function and inserts into the Pol III active-site cleft, with the cyclin-repeat subdomain contacting the Pol III subunit C34, while its C-terminal half assembles TFIIIB on DNA by providing the binding surfaces for TBP and Bdp1 [PMID:9710642, PMID:24277937]. BRF1 binds TBP through a bipartite, multi-site interface on the first TBP repeat that overlaps the surface used by Pol II factors, and it acts in concert with its TFIIB-homology domain to dissociate TBP dimers and dramatically stabilize the TBP–Bdp1 interaction [PMID:8662956, PMID:9488486, PMID:15190063]; a 66-residue C-terminal segment serves as a two-sided adhesive that anchors Bdp1 via its conserved SANT domain [PMID:16551611, PMID:19086269]. BRF1 is recruited into the TFIIIB–TFIIIC–DNA complex through multiple peptide contacts with the TPR repeats of the TFIIIC subunit Tfc4, an interaction subject to Tfc4 autoinhibition that is relieved by conformational change [PMID:12930823, PMID:16880507]. Distinct human BRF1 splice variants confer promoter-type specificity, functioning at gene-internal tRNA-type promoters while a separate variant serves the U6-type promoter [PMID:8943358, PMID:10921893]. BRF1 expression and activity are heavily regulated: it is repressed by Maf1 and during p53-mediated arrest, ubiquitinated by RNF12, and transcriptionally driven by c-Jun, Sp1, and ERα to tune Pol III output [PMID:11283026, PMID:17505538, PMID:30413534, PMID:32115405, PMID:28972307]. Biallelic activity-reducing BRF1 mutations cause cerebellar hypoplasia and intellectual disability, and Brf1 is essential for blastocyst viability and tissue homeostasis in mice [PMID:25561519, PMID:30858608]. The second, unrelated protein sharing the BRF1 name is the ARE-binding zinc-finger mRNA decay factor (ZFP36L1/TIS11b), which destabilizes ARE-containing mRNAs by recruiting deadenylation, decapping, and exonucleolytic decay enzymes through two activation domains and delivering transcripts to processing bodies [PMID:12198173, PMID:15687258, PMID:17369404]; its decay activity is suppressed by PKB phosphorylation at S92/S203 driving 14-3-3 sequestration and by MK2, while PKA phosphorylation at S334 switches its association between Dcp1a and Cnot1, and it acts downstream of FGF/ERK to destabilize Nanog mRNA and limit pluripotency [PMID:15538381, PMID:17030608, PMID:18326031, PMID:27708140, PMID:24733888].","teleology":[{"year":1994,"claim":"Establishing the molecular partners of BRF defined it as the bridging subunit of TFIIIB, answering how Pol III machinery is tethered to TBP and TFIIIC.","evidence":"Protein-protein binding assays of BRF fragments with TFIIIC, TBP and Pol III subunit C34 in yeast","pmids":["7995525"],"confidence":"High","gaps":["Did not resolve the bipartite vs single-site nature of TBP binding","No structural model of the contacts"]},{"year":1996,"claim":"Purification of human BRF1 as a TBP-associated factor and its immunodepletion established that hBRF is required specifically for gene-internal (tRNA-type) but not TATA-type Pol III promoters.","evidence":"Biochemical purification, cloning, and immunodepletion followed by in vitro transcription from VAI and U6 promoters","pmids":["8943358"],"confidence":"High","gaps":["Did not explain the molecular basis of promoter-type discrimination","Identity of the U6-specific factor unresolved at this point"]},{"year":1996,"claim":"Reconstitution from recombinant subunits showed BRF1 enhances the weak TBP–Bdp1 interaction >25-fold and that BRF1/Bdp1 occupy TBP surfaces shared with Pol II factors, defining BRF1 as the assembly nucleator of TFIIIB.","evidence":"Recombinant TFIIIB reconstitution, quantitative binding assays, and competition with TFIIA/TFIIB","pmids":["8662956"],"confidence":"High","gaps":["Precise residues on TBP not yet mapped","Stoichiometry and kinetics of assembly not fully defined"]},{"year":1997,"claim":"Deletion analysis revealed functional complementarity between the BRF1 and Bdp1 subunits, showing the C-terminal half alone supports TBP/Bdp1 binding and complex assembly independent of the TFIIB-homology domain.","evidence":"N-terminal deletion series tested in TFIIIB-DNA assembly and TFIIIC-independent in vitro transcription","pmids":["9271407"],"confidence":"High","gaps":["Did not assign specific transcription steps to the N-terminal domain","Mechanism of subunit reciprocity left open"]},{"year":1998,"claim":"Systematic mutagenesis of TBP and dissection of BRF1 fragments defined the modular architecture: TBP binding maps to a defined surface on the first repeat, assembly function to a C-proximal segment, and transcription-directing function to the N-terminal TFIIB-homology half.","evidence":"91 TBP surface mutants in gel-shift and transcription assays; BRF fragment library with footprinting and protein-DNA cross-linking","pmids":["9488486","9710642"],"confidence":"High","gaps":["High-resolution structure of the contacts still lacking","How the two halves cooperate during initiation not resolved"]},{"year":2000,"claim":"Demonstration that BRF1 partners with TRF1 rather than TBP in Drosophila, and that splice variants confer distinct promoter specificity in human, established context-dependent flexibility of BRF1-containing TFIIIB complexes.","evidence":"IP, immunodepletion/reconstitution, and polytene colocalization in fly; isoform cDNA isolation and promoter-specific in vitro transcription in human","pmids":["10850489","10921893"],"confidence":"High","gaps":["Determinants of TBP-vs-TRF1 selection not defined","Structural basis of promoter discrimination by isoforms unresolved"]},{"year":2000,"claim":"Recombinant BRF1+TBP over the SNR6 TATA box sufficed to direct Ty3 integration, showing the minimal TFIIIB scaffold positions both Pol III initiation and retroviral integration machinery.","evidence":"In vitro integration assay with recombinant BRF1 and TBP in a TFIIIC-independent system","pmids":["10882723"],"confidence":"High","gaps":["Generality beyond SNR6/TATA promoters not tested","Physical link to integrase not mapped"]},{"year":2001,"claim":"Linking human BRF1 (TAF3B2) protein stability to p53-mediated arrest established control of Pol III capacity through regulated BRF1 abundance.","evidence":"Complementation with in vitro transcription and protein stability analysis in p53-arrested cells","pmids":["11283026"],"confidence":"Medium","gaps":["Degradation pathway not identified at this stage","Direct vs indirect p53 effect unresolved"]},{"year":2002,"claim":"Identification of a distinct ARE-binding zinc-finger BRF1 (ZFP36L1) via genetic rescue established a completely separate protein that actively drives ARE-dependent mRNA decay and antagonizes PI3K-mediated stabilization.","evidence":"Retroviral cDNA rescue of decay-deficient cells, siRNA knockdown, and zinc-finger mutagenesis","pmids":["12198173"],"confidence":"High","gaps":["Decay enzymes recruited not yet identified","Relationship to the Pol III BRF1 is purely nominal (name collision)"]},{"year":2002,"claim":"Discovery of the PCF1-1 gain-of-function mutation in Tfc4 showed BRF1 recruitment is gated by Tfc4 autoinhibition that can be relieved by conformational change.","evidence":"Site-directed mutagenesis, modeling, and affinity assays for BRF1 and Bdp1 with TFIIIC131 fragments","pmids":["12167707"],"confidence":"Medium","gaps":["BRF1 does not bind at the mutation site — conformational mechanism inferred not directly observed","Structural state of relieved autoinhibition not solved"]},{"year":2003,"claim":"Mapping overlapping BRF1 and Bdp1 binding sites on Tfc4 TPRs explained how the two TFIIIB subunits are competitively recruited onto the TFIIIC scaffold.","evidence":"Mutagenesis of Tfc4 TPR residues with assembly and direct binding assays plus multicopy suppression","pmids":["12930823"],"confidence":"High","gaps":["Order of recruitment during assembly not fully resolved","Structure of the Tfc4-BRF1 interface lacking"]},{"year":2004,"claim":"PKB phosphorylation of the ARE-decay BRF1 at S92 and demonstration of BRF1-driven TBP dimer dissociation in the transcription protein together defined active regulatory mechanisms in both namesake proteins.","evidence":"In vitro decay/kinase assays, S92A mutagenesis and 14-3-3 co-IP (ZFP36L1); in vitro TBP dimerization assays with domain fragments (Pol III BRF1)","pmids":["15538381","15190063"],"confidence":"High","gaps":["Whether a second phospho-site cooperates with S92 not yet known","Structural basis of dimer dissociation not determined"]},{"year":2005,"claim":"Defining two activation domains on ARE-decay BRF1 that recruit deadenylation, decapping and exonucleolytic enzymes established it as a modular platform for assembling the mRNA decay machinery; engineering a BRF1-TBP triple fusion confirmed the modular bipartite TBP-interaction mode of the Pol III BRF1.","evidence":"Co-IP of decay enzymes, tethering and dominant-negative assays (ZFP36L1); triple-fusion reconstitution with footprinting and in vivo complementation (Pol III BRF1)","pmids":["15687258","16227432"],"confidence":"High","gaps":["Direct vs indirect contact of each decay enzyme not all resolved","Bdp1-independent recruitment in fusion vs native context differences"]},{"year":2006,"claim":"Residue-level mapping of the BRF1–Bdp1 interface (66-aa two-sided adhesive engaging the Bdp1 SANT domain) and demonstration of a second PKB site (S203) cooperating with S92 in the decay protein refined the molecular models for both proteins.","evidence":"Mutagenesis/cross-linking of BRF1-Bdp1 segments (Pol III); kinase, mutagenesis, fractionation and KO-cell stability assays for S92/S203 14-3-3 sequestration (ZFP36L1); genome-wide ChIP of TRF1/BRF in fly","pmids":["16551611","17030608","17170711"],"confidence":"High","gaps":["Atomic structure of the BRF1-Bdp1 interface not yet at NMR resolution here","Genome-wide BRF1 targets in mammals not defined"]},{"year":2007,"claim":"Placing Maf1 repression directly through BRF1/Brf2 and showing ARE-decay BRF1 delivers mRNAs to processing bodies positioned both proteins within their respective regulatory pathways.","evidence":"Pol III luciferase reporter epistasis (Maf1); siRNA depletion, dominant-negative, tethering and live imaging of ARE-mRNAs in PBs","pmids":["17505538","17369404"],"confidence":"Medium","gaps":["Direct Maf1-BRF1 contact not biochemically mapped here","PB localization step relative to decay completion not fully ordered"]},{"year":2008,"claim":"MK2 phosphorylation of ARE-decay BRF1 at S54/S92/S203 inhibits decay downstream of RNA binding and enzyme recruitment, distinguishing the regulatory step from substrate engagement.","evidence":"In vitro kinase, site-directed mutagenesis, decay assays, ARE binding and decay-enzyme co-IP","pmids":["18326031"],"confidence":"High","gaps":["Identity of the C-terminal MK2 site not determined","Mechanism downstream of recruitment that blocks decay unresolved"]},{"year":2008,"claim":"NMR mapping localized the principal BRF1 anchorage on the convex SANT-domain surface of Bdp1 (residues 470–495 of BRF1), giving a residue-resolution model of the TFIIIB core interface.","evidence":"NMR chemical shift perturbation with minimal functional Brf1/Bdp1 segments","pmids":["19086269"],"confidence":"High","gaps":["Full-length complex structure not solved","DNA-bound conformation of the interface not captured"]},{"year":2010,"claim":"Identifying c-Jun/JNK1 induction of BRF1 and TBP expression connected Pol III transcriptional capacity to stress and ethanol signaling at the level of TFIIIB abundance.","evidence":"ChIP of c-Jun at the BRF1 promoter, reporters, siRNA, and an in vivo mouse alcohol model","pmids":["21106530"],"confidence":"Medium","gaps":["Direct enzymatic link from JNK1 to BRF1 promoter not isolated","Physiological consequence of elevated Pol III output not defined"]},{"year":2011,"claim":"Demonstration that the ARE-decay BRF1 (Tis11b) represses Dll4 by interfering with 3'-end cleavage/polyadenylation extended its repertoire beyond classical decay into co-transcriptional/processing control.","evidence":"siRNA, RNA-IP of endogenous Dll4 mRNA, 3'-UTR reporters and poly(A) site usage analysis","pmids":["21832157"],"confidence":"Medium","gaps":["Generality across other targets not established","Mechanistic link to the cleavage/polyadenylation machinery not mapped"]},{"year":2013,"claim":"Site-specific cross-linking in the native preinitiation complex mapped the full BRF1 interaction network, showing the N-terminal domain behaves like TFIIB in the Pol III cleft and contacts C34, while the C-terminal domain holds TBP and Bdp1 on the promoter.","evidence":"Non-natural amino acid cross-linking and hydroxyl radical probing in the Pol III PIC","pmids":["24277937"],"confidence":"High","gaps":["Dynamic transitions during open-complex formation not captured","Quantitative contributions of each contact to initiation not measured"]},{"year":2014,"claim":"Positioning ARE-decay BRF1 downstream of FGF/ERK to destabilize Nanog mRNA established a signaling-to-mRNA-decay axis controlling pluripotency and lineage commitment.","evidence":"FGF/ERK manipulation with Brf1 gain/loss-of-function and mRNA stability/differentiation assays in mESCs","pmids":["24733888"],"confidence":"Medium","gaps":["Direct vs indirect ERK control of Brf1 not fully separated","Full target set beyond Nanog not catalogued"]},{"year":2015,"claim":"Identifying biallelic activity-reducing BRF1 mutations that lower tRNA-gene occupancy and Pol III transcription, with cross-species recapitulation, established BRF1 loss-of-function as the cause of cerebellar hypoplasia and intellectual disability.","evidence":"Exome sequencing, yeast complementation with disease alleles, ChIP occupancy, in vitro Pol III transcription, and zebrafish CRISPR/morpholino","pmids":["25561519"],"confidence":"High","gaps":["Tissue-specific basis of the neurodevelopmental phenotype not resolved","Which Pol III transcripts drive pathology not pinpointed"]},{"year":2016,"claim":"Showing PKA phosphorylation of ARE-decay BRF1 at S334 switches its association between Dcp1a and Cnot1 revealed phosphorylation-driven routing between distinct decay pathways and stabilization of the protein.","evidence":"Kinase assays, phosphomimetic mutagenesis, half-life measurement and co-IP with Dcp1a and Cnot1","pmids":["27708140"],"confidence":"High","gaps":["Physiological signals driving S334 phosphorylation in vivo not defined","Net effect on specific endogenous targets not mapped"]},{"year":2018,"claim":"Identifying RNF12-mediated K27/K33-linked ubiquitination of Pol III BRF1 and the Rpc82 WH3 contact within the PIC added a degradative regulatory input and a new Pol III subunit contact to the transcription-factor BRF1.","evidence":"Co-IP, in vitro ubiquitination with linkage analysis and Pol III/proliferation assays (RNF12); site-specific photo-crosslinking with functional assays (Rpc82)","pmids":["30413534","29177422"],"confidence":"Medium","gaps":["Whether K27/K33 chains target BRF1 for degradation or signaling unresolved","Functional consequence of the Rpc82 WH3-BRF1 contact for initiation not quantified"]},{"year":2019,"claim":"Conditional and constitutive Brf1 knockout in mice established that the Pol III transcription factor is essential for blastocyst viability and adult tissue homeostasis, with loss inducing apoptosis rescuable by re-expression.","evidence":"Conditional KO mouse models, genetic rescue, histology and apoptosis assays","pmids":["30858608"],"confidence":"High","gaps":["Tissue-specific transcript dependencies not defined","Threshold of Pol III activity for survival not determined"]},{"year":2020,"claim":"Showing Sp1 and ERα drive BRF1 expression and promoter occupancy connected upstream Pol II transcription factors to the regulation of Pol III capacity through BRF1 abundance.","evidence":"Reporter assays, ChIP of Sp1/TBP/TFIIAα/p300 at the BRF1 promoter, and knockdown/overexpression (Sp1); co-IP, colocalization and ChIP with siRNA/tamoxifen (ERα)","pmids":["32115405","28972307"],"confidence":"Medium","gaps":["Direct functional consequence of ERα-BRF1 physical interaction beyond expression unclear","Crosstalk between Sp1- and ERα-driven control not integrated"]},{"year":null,"claim":"It remains unresolved how the bipartite BRF1 contacts are dynamically remodeled during Pol III open-complex formation and promoter escape, and the full in vivo target spectrum and tissue-specific essential transcripts underlying BRF1-related disease are uncharacterized.","evidence":"No discovery in the corpus captures the dynamic transitions of BRF1 within an actively initiating Pol III complex or the disease-relevant target set","pmids":[],"confidence":"Low","gaps":["No cryo-EM/structural snapshot of dynamic initiation states in the corpus","Tissue-specific Pol III transcript dependencies driving disease undefined","Integration of the two namesake proteins (if any biological overlap) not addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,5,8,27]},{"term_id":"GO:0140223","term_label":"general transcription initiation factor activity","supporting_discovery_ids":[1,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,27]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,18,24]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[10,15,26]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,31]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[6,25]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,5,8,27]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[10,15,22]}],"complexes":["TFIIIB","Pol III preinitiation complex"],"partners":["TBP","BDP1","TFC4","C34","RNF12","ESR1","DCP1A","CNOT1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92994","full_name":"Transcription factor IIIB 90 kDa subunit","aliases":["B-related factor 1","BRF-1","hBRF","TAF3B2","TATA box-binding protein-associated factor, RNA polymerase III, subunit 2"],"length_aa":677,"mass_kda":73.8,"function":"General activator of RNA polymerase which utilizes different TFIIIB complexes at structurally distinct promoters. The isoform 1 is involved in the transcription of tRNA, adenovirus VA1, 7SL and 5S RNA. Isoform 2 is required for transcription of the U6 promoter","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q92994/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/BRF1","classification":"Common Essential","n_dependent_lines":1207,"n_total_lines":1208,"dependency_fraction":0.9991721854304636},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TBP","stoichiometry":10.0},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"POLR1C","stoichiometry":0.2},{"gene":"POLR2F","stoichiometry":0.2},{"gene":"POLR2H","stoichiometry":0.2},{"gene":"POLR2K","stoichiometry":0.2},{"gene":"POLR3B","stoichiometry":0.2},{"gene":"POLR3F","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/BRF1","total_profiled":1310},"omim":[{"mim_id":"617456","title":"POLYMERASE III, RNA, SUBUNIT G; POLR3G","url":"https://www.omim.org/entry/617456"},{"mim_id":"617455","title":"POLYMERASE III, RNA, SUBUNIT F; POLR3F","url":"https://www.omim.org/entry/617455"},{"mim_id":"617454","title":"POLYMERASE III, RNA, SUBUNIT C; POLR3C","url":"https://www.omim.org/entry/617454"},{"mim_id":"616202","title":"CEREBELLOFACIODENTAL SYNDROME; CFDS","url":"https://www.omim.org/entry/616202"},{"mim_id":"607013","title":"BRF2 SUBUNIT OF RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR; BRF2","url":"https://www.omim.org/entry/607013"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nuclear bodies","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/BRF1"},"hgnc":{"alias_symbol":["TFIIIB90","BRF","hBRF"],"prev_symbol":["TAF3B2","TAF3C","GTF3B"]},"alphafold":{"accession":"Q92994","domains":[{"cath_id":"2.20.25.10","chopping":"1-33","consensus_level":"medium","plddt":82.9627,"start":1,"end":33},{"cath_id":"1.10.472.10","chopping":"83-181","consensus_level":"high","plddt":92.7648,"start":83,"end":181},{"cath_id":"1.10.472.10","chopping":"183-292","consensus_level":"medium","plddt":91.373,"start":183,"end":292}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92994","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92994-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92994-F1-predicted_aligned_error_v6.png","plddt_mean":69.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BRF1","jax_strain_url":"https://www.jax.org/strain/search?query=BRF1"},"sequence":{"accession":"Q92994","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92994.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92994/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92994"}},"corpus_meta":[{"pmid":"15687258","id":"PMC_15687258","title":"Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1.","date":"2005","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15687258","citation_count":413,"is_preprint":false},{"pmid":"17369404","id":"PMC_17369404","title":"TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17369404","citation_count":201,"is_preprint":false},{"pmid":"12198173","id":"PMC_12198173","title":"Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12198173","citation_count":183,"is_preprint":false},{"pmid":"14976220","id":"PMC_14976220","title":"Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/14976220","citation_count":159,"is_preprint":false},{"pmid":"21278925","id":"PMC_21278925","title":"The roles of TTP and BRF proteins in regulated mRNA decay.","date":"2011","source":"Wiley interdisciplinary reviews. RNA","url":"https://pubmed.ncbi.nlm.nih.gov/21278925","citation_count":133,"is_preprint":false},{"pmid":"15538381","id":"PMC_15538381","title":"The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15538381","citation_count":125,"is_preprint":false},{"pmid":"7995525","id":"PMC_7995525","title":"Conserved functional domains of the RNA polymerase III general transcription factor BRF.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7995525","citation_count":114,"is_preprint":false},{"pmid":"25561519","id":"PMC_25561519","title":"BRF1 mutations alter RNA polymerase III-dependent transcription and cause neurodevelopmental anomalies.","date":"2015","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/25561519","citation_count":94,"is_preprint":false},{"pmid":"10850489","id":"PMC_10850489","title":"A TRF1:BRF complex directs Drosophila RNA polymerase III transcription.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10850489","citation_count":86,"is_preprint":false},{"pmid":"17030608","id":"PMC_17030608","title":"BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17030608","citation_count":79,"is_preprint":false},{"pmid":"18326031","id":"PMC_18326031","title":"The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2.","date":"2008","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18326031","citation_count":72,"is_preprint":false},{"pmid":"8943358","id":"PMC_8943358","title":"RNA polymerase III transcription from the human U6 and adenovirus type 2 VAI promoters has different requirements for human BRF, a subunit of human TFIIIB.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8943358","citation_count":67,"is_preprint":false},{"pmid":"10882723","id":"PMC_10882723","title":"The Brf and TATA-binding protein subunits of the RNA polymerase III transcription factor IIIB mediate position-specific integration of the gypsy-like element, Ty3.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10882723","citation_count":64,"is_preprint":false},{"pmid":"9710642","id":"PMC_9710642","title":"Functional and structural organization of Brf, the TFIIB-related component of the RNA polymerase III transcription initiation complex.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9710642","citation_count":58,"is_preprint":false},{"pmid":"17505538","id":"PMC_17505538","title":"Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2.","date":"2007","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17505538","citation_count":54,"is_preprint":false},{"pmid":"9271407","id":"PMC_9271407","title":"Domains of the Brf component of RNA polymerase III transcription factor IIIB (TFIIIB): functions in assembly of TFIIIB-DNA complexes and recruitment of RNA polymerase to the promoter.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9271407","citation_count":48,"is_preprint":false},{"pmid":"8662956","id":"PMC_8662956","title":"Cloning and functional characterization of the gene encoding the TFIIIB90 subunit of RNA polymerase III transcription factor TFIIIB.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8662956","citation_count":45,"is_preprint":false},{"pmid":"9488486","id":"PMC_9488486","title":"Polymerase (Pol) III TATA box-binding protein (TBP)-associated factor Brf binds to a surface on TBP also required for activated Pol II transcription.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9488486","citation_count":45,"is_preprint":false},{"pmid":"17170711","id":"PMC_17170711","title":"Novel TRF1/BRF target genes revealed by genome-wide analysis of Drosophila Pol III transcription.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17170711","citation_count":39,"is_preprint":false},{"pmid":"28972307","id":"PMC_28972307","title":"Role of Brf1 interaction with ERα, and significance of its overexpression, in human breast cancer.","date":"2017","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28972307","citation_count":37,"is_preprint":false},{"pmid":"26701855","id":"PMC_26701855","title":"The significance of Brf1 overexpression in human hepatocellular carcinoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26701855","citation_count":33,"is_preprint":false},{"pmid":"21106530","id":"PMC_21106530","title":"Alcohol induces RNA polymerase III-dependent transcription through c-Jun by co-regulating TATA-binding protein (TBP) and Brf1 expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21106530","citation_count":33,"is_preprint":false},{"pmid":"28912018","id":"PMC_28912018","title":"Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.","date":"2017","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/28912018","citation_count":31,"is_preprint":false},{"pmid":"24277937","id":"PMC_24277937","title":"Mapping the protein interaction network for TFIIB-related factor Brf1 in the RNA polymerase III preinitiation complex.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24277937","citation_count":29,"is_preprint":false},{"pmid":"16227432","id":"PMC_16227432","title":"Reconfiguring the connectivity of a multiprotein complex: fusions of yeast TATA-binding protein with Brf1, and the function of transcription factor IIIB.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16227432","citation_count":29,"is_preprint":false},{"pmid":"10921893","id":"PMC_10921893","title":"Alternatively spliced hBRF variants function at different RNA polymerase III promoters.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10921893","citation_count":27,"is_preprint":false},{"pmid":"27748960","id":"PMC_27748960","title":"BRF1 mutations in a family with growth failure, markedly delayed bone age, and central nervous system anomalies.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27748960","citation_count":26,"is_preprint":false},{"pmid":"18700021","id":"PMC_18700021","title":"Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.","date":"2008","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18700021","citation_count":25,"is_preprint":false},{"pmid":"9020796","id":"PMC_9020796","title":"Apolipoprotein B gene regulatory factor-2 (BRF-2) is structurally and immunologically highly related to hepatitis B virus X associated protein-1 (XAP-1).","date":"1997","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9020796","citation_count":25,"is_preprint":false},{"pmid":"24733888","id":"PMC_24733888","title":"Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24733888","citation_count":24,"is_preprint":false},{"pmid":"30320187","id":"PMC_30320187","title":"BRF1 ameliorates LPS-induced inflammation through autophagy crosstalking with MAPK/ERK signaling.","date":"2018","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30320187","citation_count":22,"is_preprint":false},{"pmid":"17877750","id":"PMC_17877750","title":"Vaccinia virus-mediated cell cycle alteration involves inactivation of tumour suppressors associated with Brf1 and TBP.","date":"2007","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17877750","citation_count":21,"is_preprint":false},{"pmid":"16551611","id":"PMC_16551611","title":"Mapping the principal interaction site of the Brf1 and Bdp1 subunits of Saccharomyces cerevisiae TFIIIB.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16551611","citation_count":20,"is_preprint":false},{"pmid":"12930823","id":"PMC_12930823","title":"The Brf1 and Bdp1 subunits of transcription factor TFIIIB bind to overlapping sites in the tetratricopeptide repeats of Tfc4.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12930823","citation_count":18,"is_preprint":false},{"pmid":"27708140","id":"PMC_27708140","title":"The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/27708140","citation_count":16,"is_preprint":false},{"pmid":"21832157","id":"PMC_21832157","title":"A novel function of Tis11b/BRF1 as a regulator of Dll4 mRNA 3'-end processing.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21832157","citation_count":15,"is_preprint":false},{"pmid":"8595910","id":"PMC_8595910","title":"The human immediate early gene BRF1 maps to chromosome 14q22-q24.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8595910","citation_count":15,"is_preprint":false},{"pmid":"26337955","id":"PMC_26337955","title":"BRF1, a subunit of RNA polymerase III transcription factor TFIIIB, is essential for cell growth of Trypanosoma brucei.","date":"2015","source":"Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/26337955","citation_count":14,"is_preprint":false},{"pmid":"16880507","id":"PMC_16880507","title":"Interactions of Brf1 peptides with the tetratricopeptide repeat-containing subunit of TFIIIC inhibit and promote preinitiation complex assembly.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16880507","citation_count":14,"is_preprint":false},{"pmid":"30914800","id":"PMC_30914800","title":"Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30914800","citation_count":13,"is_preprint":false},{"pmid":"32115405","id":"PMC_32115405","title":"The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling BRF1 and GTF3C2 expression in human cells.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32115405","citation_count":13,"is_preprint":false},{"pmid":"12167707","id":"PMC_12167707","title":"A gain-of-function mutation in the second tetratricopeptide repeat of TFIIIC131 relieves autoinhibition of Brf1 binding.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12167707","citation_count":12,"is_preprint":false},{"pmid":"31781337","id":"PMC_31781337","title":"Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31781337","citation_count":10,"is_preprint":false},{"pmid":"30413534","id":"PMC_30413534","title":"RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30413534","citation_count":10,"is_preprint":false},{"pmid":"30858608","id":"PMC_30858608","title":"Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30858608","citation_count":10,"is_preprint":false},{"pmid":"11283026","id":"PMC_11283026","title":"A role for TAF3B2 in the repression of human RNA polymerase III transcription in nonproliferating cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11283026","citation_count":10,"is_preprint":false},{"pmid":"32685086","id":"PMC_32685086","title":"Mitogen- and Stress-Activated Protein Kinase 1 Mediates Alcohol-Upregulated Transcription of Brf1 and tRNA Genes to Cause Phenotypic Alteration.","date":"2020","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/32685086","citation_count":9,"is_preprint":false},{"pmid":"29177422","id":"PMC_29177422","title":"The TFIIE-related Rpc82 subunit of RNA polymerase III interacts with the TFIIB-related transcription factor Brf1 and the polymerase cleft for transcription initiation.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29177422","citation_count":9,"is_preprint":false},{"pmid":"1620125","id":"PMC_1620125","title":"Transcriptional regulation of the apolipoprotein B100 gene: purification and characterization of trans-acting factor BRF-2.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1620125","citation_count":8,"is_preprint":false},{"pmid":"10463061","id":"PMC_10463061","title":"The product of the primary response gene BRF1 inhibits the interaction between 14-3-3 proteins and cRaf-1 in the yeast trihybrid system.","date":"1999","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10463061","citation_count":8,"is_preprint":false},{"pmid":"19086269","id":"PMC_19086269","title":"Structural characterization of the interaction between TFIIIB components Bdp1 and Brf1.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19086269","citation_count":8,"is_preprint":false},{"pmid":"32198086","id":"PMC_32198086","title":"The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription.","date":"2020","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/32198086","citation_count":7,"is_preprint":false},{"pmid":"33669344","id":"PMC_33669344","title":"Participation of TFIIIB Subunit Brf1 in Transcription Regulation in the Human Pathogen Leishmania major.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33669344","citation_count":7,"is_preprint":false},{"pmid":"32896090","id":"PMC_32896090","title":"Expanding the phenotype of cerebellar-facial-dental syndrome: Two siblings with a novel variant in BRF1.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/32896090","citation_count":7,"is_preprint":false},{"pmid":"9773276","id":"PMC_9773276","title":"Identification of a putative BRF homologue in the genome of Caenorhabditis elegans.","date":"1998","source":"DNA sequence : the journal of DNA sequencing and mapping","url":"https://pubmed.ncbi.nlm.nih.gov/9773276","citation_count":6,"is_preprint":false},{"pmid":"9133742","id":"PMC_9133742","title":"Analysis of a 17.9 kb region from Saccharomyces cerevisiae chromosome VII reveals the presence of eight open reading frames, including BRF1 (TFIIIB70) and GCN5 genes.","date":"1997","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9133742","citation_count":5,"is_preprint":false},{"pmid":"15190063","id":"PMC_15190063","title":"Inhibition of TATA binding protein dimerization by RNA polymerase III transcription initiation factor Brf1.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15190063","citation_count":5,"is_preprint":false},{"pmid":"33995823","id":"PMC_33995823","title":"Exploring the Role and Mechanism of pAMPKα-Mediated Dysregulation of Brf1 and RNA Pol III Genes.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/33995823","citation_count":4,"is_preprint":false},{"pmid":"34646425","id":"PMC_34646425","title":"ROS Signaling-Mediated Novel Biological Targets: Brf1 and RNA Pol III Genes.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/34646425","citation_count":3,"is_preprint":false},{"pmid":"17028095","id":"PMC_17028095","title":"The Saccharomyces cerevisiae RNA polymerase III recruitment factor subunits Brf1 and Bdp1 impose a strict sequence preference for the downstream half of the TATA box.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17028095","citation_count":3,"is_preprint":false},{"pmid":"14518004","id":"PMC_14518004","title":"Cloning of a putative Bombyx mori TFIIB-related factor (BRF).","date":"2003","source":"Archives of insect biochemistry and physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14518004","citation_count":2,"is_preprint":false},{"pmid":"39308682","id":"PMC_39308682","title":"Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39308682","citation_count":1,"is_preprint":false},{"pmid":"39229529","id":"PMC_39229529","title":"BRF1 promotes the odontogenic differentiation of dental pulp stem cells in pulpitis by inducing autophagy.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39229529","citation_count":1,"is_preprint":false},{"pmid":"39005000","id":"PMC_39005000","title":"Identification of novel variants in BRF1 gene from patient with developmental delay, hearing abnormality, and nervous system anomalies.","date":"2024","source":"International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39005000","citation_count":1,"is_preprint":false},{"pmid":"38234569","id":"PMC_38234569","title":"Retracted: ROS Signaling-Mediated Novel Biological Targets: Brf1 and RNA Pol III Genes.","date":"2024","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/38234569","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.16.628719","title":"Maf1 Cooperates with Progesterone Receptor to Repress RNA Polymerase III Transcription of Select tRNAs","date":"2024-12-16","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.16.628719","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.01.25332845","title":"Protective Dietary Antioxidants Intake Attenuate Cardiovascular-Kidney-Metabolic Syndrome Progression","date":"2025-08-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.01.25332845","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":32960,"output_tokens":10216,"usd":0.12606,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20557,"output_tokens":8207,"usd":0.15398,"stage2_stop_reason":"end_turn"},"total_usd":0.28004,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Yeast BRF (BRF1 ortholog) binds the 135-kD subunit of TFIIIC and also binds TBP; TBP interacts with both the TFIIB-homologous N-terminal half and the C-terminal half of BRF, with two conserved C-terminal regions required for the TBP–BRF C-terminal interaction. BRF also binds RNA Pol III subunit C34, and a region of C34 necessary for this interaction was defined.\",\n      \"method\": \"Protein–protein interaction assays (binding assays between BRF fragments and TFIIIC subunit, TBP, and Pol III subunit C34); functional analysis of deletion mutants; TBP mutants that selectively inhibit Pol III transcription in vivo impair the BRF C-terminal–TBP interaction\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal binding assays with deletion mutants and TBP point mutants, replicated across yeast species\",\n      \"pmids\": [\"7995525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Human BRF1 (TFIIIB90/hBRF, 88 kDa) was purified as a TBP-associated complex and identified as the human homolog of yeast BRF. Immunodepletion of hBRF severely debilitates transcription from the tRNA-type VAI promoter but does not affect transcription from the TATA box-containing human U6 promoter, indicating promoter-type-specific requirement for hBRF.\",\n      \"method\": \"Biochemical purification; cDNA cloning; immunodepletion of hBRF from transcription extracts followed by in vitro transcription from VAI and U6 promoters\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro transcription reconstitution with immunodepletion, two distinct promoter types tested\",\n      \"pmids\": [\"8943358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Yeast TFIIIB90 (Bdp1/B\\\") interacts weakly with TBP alone but this interaction is enhanced at least 25-fold by BRF1. TFIIIB was reconstituted from recombinant subunits (TBP, BRF1, TFIIIB90). Binding sites for BRF1 and TFIIIB90 on TBP-DNA overlap with binding sites for TFIIA and TFIIB, indicating shared TBP interface.\",\n      \"method\": \"Recombinant protein reconstitution; in vitro binding assays; competition with Pol II factors TFIIA and TFIIB\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution from recombinant subunits with quantitative binding measurements, multiple orthogonal assays\",\n      \"pmids\": [\"8662956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"N-terminal deletion analysis of yeast Brf1 showed that the C-terminal half (residues 317–596) lacking the entire TFIIB-homologous domain can still interact with DNA-bound TBP and with B\\\"/Bdp1. Brf1(165–596) lacking 164 N-proximal TFIIB-homologous residues is competent for TFIIIB-DNA complex assembly and TFIIIC-independent transcription, revealing functional complementarity and reciprocity between Brf1 and B\\\" subunits.\",\n      \"method\": \"N-terminal deletion series of Brf1 tested in TFIIIB-DNA complex assembly and in vitro transcription; genetic complementation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic deletion mutagenesis combined with in vitro transcription reconstitution\",\n      \"pmids\": [\"9271407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TBP surface residues on the top and side of the first TBP repeat (K181, L185, R186, E206, R231, L232, R235, K236, R239, Q242, K243, K249, F250) are required for interaction with yeast Pol III TAF Brf. The Brf C-terminal fragment (lacking TFIIB-homology region) retains TBP-DNA binding via this same surface. Brf and TFIIB interact differently with TBP; the Brf-binding surface on TBP overlaps with surfaces required for activated Pol II transcription.\",\n      \"method\": \"91 human TBP surface mutants analyzed in gel-shift assays with purified Brf and B\\\"; in vitro U6 snRNA transcription; equivalent yeast TBP mutations tested\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis of 91 TBP residues with both binding and transcription functional readouts\",\n      \"pmids\": [\"9488486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Systematic analysis of Brf fragments defined that the principal TFIIIB-assembly function maps to a C-proximal segment (aa 435–545), while the principal transcription-directing function resides in the N-proximal TFIIB-homologous half. Split Brf fragments (aa 1–282 + 284–596) reconstitute fully active TFIIIB-DNA complexes. Photochemical cross-linking mapped proximities of each Brf half to DNA, providing a global model of Brf domain organization in the TFIIIB-DNA complex.\",\n      \"method\": \"Systematic Brf fragment analysis; in vitro transcription reconstitution; in vitro footprinting; photochemical protein-DNA cross-linking; TBP interaction mapping\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — extensive fragment library tested with multiple orthogonal methods (transcription, footprinting, cross-linking)\",\n      \"pmids\": [\"9710642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In Drosophila, TRF1 (rather than TBP) forms a complex with BRF to direct RNA polymerase III transcription. Immunoprecipitation showed TRF1:BRF complex in vivo; immunodepleted extracts supplemented with recombinant TRF1 and BRF reconstitute transcription of tRNA, 5S, and U6 RNA genes. In vivo, the majority of TRF1 is complexed with BRF and the two proteins colocalize at many polytene chromosome sites containing RNA Pol III genes.\",\n      \"method\": \"Immunoprecipitation; immunodepletion followed by in vitro transcription reconstitution with recombinant proteins; immunofluorescence colocalization on polytene chromosomes\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution from recombinant proteins combined with in vivo colocalization, multiple orthogonal methods\",\n      \"pmids\": [\"10850489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Recombinant Brf and TBP subunits of TFIIIB, interacting over the SNR6 TATA box, are sufficient to direct Ty3 retrotransposon integration at the SNR6 transcription initiation site in the absence of detectable TFIIIC or TFIIIB subunit B\\\", establishing that the minimal requirements for Pol III transcription and Ty3 integration are very similar.\",\n      \"method\": \"In vitro integration assay with recombinant Brf and TBP; TFIIIC-independent system using U6/SNR6 gene with TATA box\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with defined recombinant proteins, clear functional readout\",\n      \"pmids\": [\"10882723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Alternatively spliced human BRF variants have distinct promoter specificities: hBRF1 functions at the gene-internal 5S, VA1, 7SL and EBER2 promoters, while a different variant hBRF2 is required at the gene-external human U6 promoter, demonstrating that Pol III utilizes different TFIIIB complexes at structurally distinct promoters.\",\n      \"method\": \"Isolation of alternatively spliced cDNAs; immunopurification of hBRF-containing complexes; in vitro transcription from different Pol III promoter types\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution with purified isoform-containing complexes and multiple promoter types tested\",\n      \"pmids\": [\"10921893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In human cells, a TFIIIB subcomponent containing TBP and TAF3B2 (human BRF1) is the target of repression during p53-mediated cell cycle arrest. TAF3B2 protein levels are markedly reduced in extracts from cell cycle-arrested cells due to decreased TAF3B2 protein stability, providing a mechanism for reducing Pol III transcriptional capacity.\",\n      \"method\": \"Cell-based complementation assays with in vitro transcription; protein stability analysis in p53-arrested cells; cell fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complementation assays plus protein stability measurement, single lab with two orthogonal methods\",\n      \"pmids\": [\"11283026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BRF1 (butyrate response factor 1, ZFP36L1 family) was identified as an essential regulator of ARE-dependent mRNA decay: a mutagenized cell line (slowC) failing to degrade ARE-containing mRNA carries frameshift mutations in both BRF1 alleles; retroviral re-expression rescues rapid mRNA decay. siRNA knockdown independently confirms BRF1's active role. BRF1 accelerates mRNA decay and antagonizes PI3-kinase-mediated stabilization; zinc finger mutations abolish both ARE binding and mRNA decay activity.\",\n      \"method\": \"Functional genetic screen (retroviral cDNA library rescue of decay-deficient cells); flow cytometry-based reporter assay; siRNA knockdown; transfection of BRF1 zinc finger mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue (biallelic mutations identified and complemented) plus independent siRNA validation plus mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"12198173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A gain-of-function mutation (PCF1-1, H190Y) in TPR2 of TFIIIC131 increases binding affinity of TFIIIC131 for Brf1 without affecting Bdp1 binding affinity, by overcoming autoinhibition of Brf1 binding—Brf1 does not interact directly at the mutation site, but the mutation stabilizes an alternative conformation of TFIIIC131 that promotes Brf1 interaction.\",\n      \"method\": \"Site-directed mutagenesis; structural modeling; binding affinity assays for Brf1 and Bdp1 with TFIIIC131 fragments; dominant mutation analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding assays with domain fragments and mutagenesis, single lab\",\n      \"pmids\": [\"12167707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The Brf1 and Bdp1 subunits of TFIIIB bind to overlapping sites in the tetratricopeptide repeats (TPRs) of Tfc4 (TFIIIC subunit). TPRs6–9 contain a binding site for Brf1; the L469K mutation in TPR7 reduces Brf1 recruitment into TFIIIB-TFIIIC-DNA complexes and reduces direct Tfc4–Brf1 interaction, and also decreases Bdp1 incorporation, indicating both subunits compete for overlapping Tfc4 sites.\",\n      \"method\": \"Site-directed mutagenesis of Tfc4 TPR residues; biochemical assembly assays for TFIIIB-TFIIIC-DNA complexes; direct binding assays; multicopy suppression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutagenesis combined with multiple biochemical binding and assembly assays, multicopy suppression genetics\",\n      \"pmids\": [\"12930823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Protein kinase B (PKB/Akt) phosphorylates BRF1 (ARE-decay factor) at serine 92 (S92), which impairs BRF1 mRNA decay activity without affecting ARE binding, and induces complex formation of BRF1 with the scaffold protein 14-3-3, causing ARE-mRNA stabilization.\",\n      \"method\": \"Recombinant BRF1 in vitro mRNA decay assay; in vitro PKB kinase assay; phosphorylation-site mutagenesis (S92A); co-immunoprecipitation of BRF1 with 14-3-3; ARE-mRNA stability measurements in vivo\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstituted decay assay plus kinase assay plus mutagenesis plus co-IP, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15538381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Brf1 (yeast) induces dissociation of TBP dimers, requiring both its high-affinity TBP-binding C-terminal domain and its TFIIB homology domain working in concert; the C-terminal TBP-binding domain alone is insufficient to promote TBP dimer dissociation.\",\n      \"method\": \"In vitro TBP dimerization and dissociation assays with Brf1 domain fragments; functional domain analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical assay with domain dissection, single lab\",\n      \"pmids\": [\"15190063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TTP and BRF-1 (ARE-decay factors) each contain two activation domains that recruit mRNA decay enzymes involved in deadenylation, decapping, 3'-to-5' exonucleolytic decay, and 5'-to-3' exonucleolytic decay. The N-terminal activation domain of BRF-1 functions as a binding platform for mRNA decay enzymes. Both activation domains can activate mRNA decay when fused to a heterologous RNA-binding protein and inhibit ARE-mediated mRNA decay when overexpressed.\",\n      \"method\": \"Co-immunoprecipitation of mRNA decay enzymes with TTP/BRF-1; tethering assays (fusion to heterologous RNA-binding protein); dominant-negative overexpression; two activation domain mapping\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP with multiple decay enzymes, functional tethering assays, domain mapping, replicated for both TTP and BRF-1\",\n      \"pmids\": [\"15687258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A Brf1-TBP triple fusion protein (TBP core placed between N- and C-proximal domains of Brf1) effectively replaces both Brf1 and TBP in TFIIIC-dependent and -independent transcription in vitro, forms extremely stable TFIIIB-DNA complexes, and can recruit Pol III for TATA box-directed transcription in the absence of Bdp1, confirming the modular architecture of Brf1 and its bipartite TBP interaction mode.\",\n      \"method\": \"Structure-informed protein engineering (triple fusion); in vitro transcription reconstitution; chemical nuclease footprinting; in vivo complementation in yeast\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with engineered fusion protein, in vitro and in vivo validation, footprinting\",\n      \"pmids\": [\"16227432\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKB phosphorylates BRF1 (ARE-decay factor) at a second regulatory site, S203, which cooperates with S92 in vivo. Double alanine mutation of both S92 and S203 uncouples BRF1 from PKB regulation, leading to constitutive mRNA decay. Phosphorylation-dependent 14-3-3 binding requires phosphorylation at both sites. BRF1 is subject to proteasomal degradation (half-life <3 h) but phosphorylation stabilizes it; cell compartment fractionation showed that 14-3-3 binding sequesters BRF1 through relocalization, preventing mRNA decay activity and protecting from proteasomal degradation.\",\n      \"method\": \"In vitro kinase assay; site-directed mutagenesis (S92A, S203A, double mutant); mRNA decay assays; co-immunoprecipitation with 14-3-3; protein stability assays in PKBα−/− cells; cell fractionation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (kinase assay, mutagenesis, stability assays, fractionation, KO cells), single rigorous study\",\n      \"pmids\": [\"17030608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The principal attachment site of Brf1 for Bdp1 in TFIIIB was mapped: a 66-amino acid segment of Brf1's C-terminal half serves as a two-sided adhesive surface with one face interacting with TBP and the other anchoring Bdp1. The interacting Bdp1 domain was demarcated to a 66-amino acid segment including the SANT domain, which is the most phylogenetically conserved region of Bdp1.\",\n      \"method\": \"Structure-informed site-directed mutagenesis; photochemical protein-DNA cross-linking; deletion series of Brf1 and Bdp1 fragments in binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic mutagenesis plus photochemical cross-linking, multiple deletion constructs mapped\",\n      \"pmids\": [\"16551611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Brf1 peptides from three distinct regions interact with the TPR-containing Tfc4 subunit of TFIIIC. A peptide binding specifically to TPR6-9 of Tfc4 promotes formation of TFIIIC-DNA and Brf1-TFIIIC-DNA complexes and causes a conformational change in TFIIIC that overcomes Tfc4 autoinhibition of Brf1 binding, suggesting repositioning of Brf1 is required during TFIIIB assembly.\",\n      \"method\": \"Yeast two-hybrid screen of Brf1 peptide libraries against Tfc4 fragments; native gel mobility shift assays; biochemical binding studies\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two-hybrid plus native gel assays, single lab with two orthogonal methods\",\n      \"pmids\": [\"16880507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Drosophila, genome-wide ChIP analysis identified 354 TRF1-binding sites, ~78% of which colocalize with BRF. The TRF1/BRF complex is functionally required for transcription of novel targets including 7SL RNA and small nucleolar RNAs, indicating TRF1/BRF is responsible for all known classes of Pol III transcription in Drosophila.\",\n      \"method\": \"Genome-wide ChIP with tiling microarrays; functional transcription assays for novel targets\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP plus functional transcription assays, single lab\",\n      \"pmids\": [\"17170711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Human Maf1 represses RNA Pol III transcription via direct interaction with TFIIIB, specifically through the TFIIB family members Brf1 and Brf2 (not through other components). This was demonstrated in vivo with a Pol III luciferase reporter assay.\",\n      \"method\": \"RNA Pol III luciferase reporter assay in vivo; epistasis analysis showing Maf1 repression acts through Brf1 and Brf2 subunits of TFIIIB\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo reporter assay with epistasis, single lab, pathway placement established\",\n      \"pmids\": [\"17505538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TTP and BRF-1 (ARE-binding proteins) deliver ARE-mRNAs to processing bodies (PBs). Depletion of endogenous TTP and BRF proteins or dominant-negative TTP impairs ARE-mRNA localization to PBs. TTP and BRF-1 can tether mRNAs to PBs and TTP can nucleate PB formation on untranslated mRNAs. ARE-mRNA PB localization is mediated by TTP N- and C-terminal domains and occurs downstream from polysome release.\",\n      \"method\": \"siRNA depletion of TTP and BRF proteins; dominant-negative overexpression; tethering assays; fluorescence microscopy/live imaging of reporter ARE-mRNAs in PBs; cycloheximide treatment to trap polysomes\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (depletion, dominant-negative, tethering, live imaging), pathway positioning established\",\n      \"pmids\": [\"17369404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MAPK-activated protein kinase 2 (MK2) phosphorylates BRF1 (ARE-decay factor) at S54, S92, S203, and an unidentified C-terminal site, inhibiting BRF1's ARE mRNA decay activity. MK2-mediated inhibition requires phosphorylation at S54, S92, and S203. Phosphorylation by MK2 does not alter BRF1's ability to bind AREs or associate with mRNA decay enzymes, suggesting inhibition occurs downstream of RNA binding and decay enzyme recruitment.\",\n      \"method\": \"In vitro kinase assays with MK2 and BRF1 fragments; site-directed mutagenesis (S54, S92, S203); ARE-mRNA decay assays in cells with active MK2; ARE-binding and co-immunoprecipitation of decay enzymes\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional mRNA decay assay plus RNA binding and co-IP, multiple orthogonal methods\",\n      \"pmids\": [\"18326031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NMR mapping of the Brf1–Bdp1 interaction at single-amino acid resolution showed that the principal anchorage site of Brf1 is on a convex surface of Bdp1 encompassing helix 1 and helix 3 of its conserved SANT domain, with the main Bdp1 anchorage provided by residues 470–495 of Brf1.\",\n      \"method\": \"NMR chemical shift perturbation mapping using minimal functional segments of Brf1 and Bdp1; NMR-derived structural model\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural mapping at residue resolution with functional segments, single lab\",\n      \"pmids\": [\"19086269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ethanol induces RNA Pol III-dependent transcription in HepG2 cells and primary mouse hepatocytes by upregulating BRF1 and TBP expression (TFIIIB components) through JNK1 activation and enhanced c-Jun expression. c-Jun is directly recruited to TBP, BRF1, and tRNA gene promoters. Chronic alcohol administration in mice increases BRF1, TBP, tRNA, and 5S rRNA transcription in liver.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); luciferase reporter assays; siRNA knockdown; in vivo mouse alcohol feeding model; quantitative RT-PCR\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP showing direct c-Jun recruitment to BRF1 promoter, in vitro and in vivo validation, single lab\",\n      \"pmids\": [\"21106530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tis11b/BRF1 (ARE-decay factor) binds to endogenous Dll4 mRNA and represses its expression without affecting mRNA stability, through a novel mechanism involving mRNA 3'-end processing. One AUUUA motif in a weak noncanonical polyadenylation signal in the Dll4 3'-UTR is the major Tis11b-binding site. Inhibition of Tis11b expression changes the ratio between mRNAs cleaved or read-through at the poly(A) signal, indicating Tis11b interferes with mRNA cleavage and polyadenylation efficiency.\",\n      \"method\": \"siRNA knockdown of Tis11b in endothelial cells; RNA immunoprecipitation of endogenous Dll4 mRNA; 3'-UTR reporter assays; poly(A) site usage analysis; hypoxia treatment\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-IP plus functional reporter assays plus poly(A) site analysis, single lab with multiple methods\",\n      \"pmids\": [\"21832157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Site-specific non-natural amino acid cross-linking mapped Brf1's protein interaction network in the Pol III preinitiation complex: the N-terminal domain of Brf1 shows multiple protein interactions in the Pol III active-site cleft reminiscent of TFIIB, with the cyclin repeat subdomain additionally contacting C34 at its WH2–WH3 connecting region. The C-terminal domain of Brf1 contains extensive binding sites for TBP and Bdp1 to hold TFIIIB together on the promoter.\",\n      \"method\": \"Site-specific non-natural amino acid incorporation for cross-linking; site-directed hydroxyl radical probing; protein interaction mapping in the preinitiation complex\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-specific cross-linking with non-natural amino acids plus hydroxyl radical probing, comprehensive domain mapping in native PIC\",\n      \"pmids\": [\"24277937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Brf1 (ZFP36L1/mRNA decay factor) operates downstream of FGF/ERK MAP kinase signaling in mouse embryonic stem cells: ERK signaling upregulates Brf1, which directly destabilizes target mRNAs including Nanog mRNA to disrupt pluripotency-associated gene expression and attenuate mESC self-renewal. Enhanced Brf1 expression preferentially regulates mesendoderm commitment during differentiation, accelerating primitive streak marker expression.\",\n      \"method\": \"FGF/ERK pathway manipulation; Brf1 gain-of-function and loss-of-function in mESCs; mRNA stability assays for Nanog and other targets; differentiation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis established with gain- and loss-of-function, direct target mRNA destabilization measured, single lab\",\n      \"pmids\": [\"24733888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Biallelic missense mutations in BRF1 reduce Brf1 occupancy at tRNA target genes in S. cerevisiae, impair yeast cell growth, and reduce Pol III-related transcription activity in vitro. CRISPR-mediated deletion of brf1 in zebrafish recapitulates neurodevelopmental phenotypes. In vivo complementation showed all four candidate disease mutations to be pathogenic in an isoform-specific context, confirming BRF1 mutations that reduce protein activity cause cerebellar hypoplasia and intellectual disability.\",\n      \"method\": \"Whole-exome sequencing; yeast complementation with human BRF1 disease alleles; ChIP for Brf1 occupancy at tRNA genes in yeast; in vitro Pol III transcription assay; CRISPR deletion and morpholino knockdown in zebrafish\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro transcription assay + ChIP occupancy + in vivo zebrafish complementation + yeast genetics, multiple orthogonal methods\",\n      \"pmids\": [\"25561519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TIS11b/BRF1 (ARE-decay factor) is phosphorylated by PKA at S54 and S334. Phosphomimetic mutation at C-terminal S334 markedly increases TIS11b half-life and enhances mRNA decay activity; this is accompanied by enhanced interaction with the decapping coactivator Dcp1a. Prevention of phosphorylation at S334 potentiates interaction with the Ccr4-Not deadenylase complex subunit Cnot1, revealing that differential phosphorylation at S334 switches TIS11b's association between distinct decay pathway components.\",\n      \"method\": \"Site-directed mutagenesis; in vitro kinase assays; phosphosite-specific immunodetection; protein half-life measurements; co-immunoprecipitation with Dcp1a and Cnot1; mRNA decay assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — kinase assay plus mutagenesis plus co-IP with decay machinery components plus functional mRNA decay readout, multiple orthogonal methods\",\n      \"pmids\": [\"27708140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BRF1 (TFIIIB subunit) physically interacts with estrogen receptor alpha (ERα) in breast cancer cells, as shown by co-immunoprecipitation and colocalization in the nucleus. ERα mediates BRF1 expression, and BRF1 and ERα synergistically regulate transcription of Pol III genes. Inhibition of ERα by siRNA or tamoxifen reduces BRF1 levels and Pol III gene expression.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence colocalization; ChIP; siRNA knockdown of ERα; tamoxifen treatment; Pol III gene expression analysis\",\n      \"journal\": \"Molecular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP and colocalization with ChIP, single lab, multiple methods but no in vitro reconstitution\",\n      \"pmids\": [\"28972307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RNF12, a RING domain-containing ubiquitin E3 ligase, physically interacts with BRF1 (TFIIIB subunit) and catalyzes Lys27- and Lys33-linked polyubiquitination of BRF1. RNF12 negatively regulates Pol III-dependent transcription and cell proliferation via BRF1.\",\n      \"method\": \"Co-immunoprecipitation; in vitro ubiquitination assay; linkage-specific ubiquitin chain analysis; Pol III transcription assays; cell proliferation assays with RNF12 overexpression/knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro ubiquitination reconstitution plus co-IP plus functional transcription readout, single lab\",\n      \"pmids\": [\"30413534\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The WH3 insertion domain of Rpc82 (TFIIE-related Pol III subunit) interacts with BRF1 within the preinitiation complex, as revealed by site-specific photo-crosslinking. Rpc82 also contacts upstream DNA and the protrusion and wall domains of the Pol III cleft, with the WH3 insertion important for cell growth and in vitro transcription activity.\",\n      \"method\": \"Site-specific photo-crosslinking with non-natural amino acid; hydroxyl radical probing; in vitro transcription assays; genetic growth assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific cross-linking plus functional assays, single lab\",\n      \"pmids\": [\"29177422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Brf1 knockout in mice leads to embryonic lethality at the blastocyst stage. Conditional deletion of Brf1 in gastrointestinal epithelial tissues (intestine, liver, pancreas) is incompatible with organ homeostasis and induces apoptosis. Overexpression of BRF1 rescues the phenotypes of Brf1 deletion in intestine and liver, confirming BRF1 is essential for normal tissue homeostasis.\",\n      \"method\": \"Conditional knockout mouse models; genetic rescue by BRF1 overexpression; histological analysis; apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with defined apoptotic phenotype plus genetic rescue, in vivo mammalian model\",\n      \"pmids\": [\"30858608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Sp1 controls BRF1 expression by binding to the BRF1 promoter 4 (BRF1P4) and promoting occupancy of TBP, TFIIAα, and p300 at this promoter, thereby modulating Pol III gene transcription. Sp1 knockdown inhibits BRF1 expression and Pol III transcription; Sp1 overexpression enhances these activities.\",\n      \"method\": \"Reporter gene assays; ChIP for Sp1, TBP, TFIIAα, p300 at BRF1 promoter; siRNA knockdown and overexpression of Sp1; Pol III transcription assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus knockdown/OE, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"32115405\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BRF1 (human TFIIIB90/hBRF, a TFIIB-related factor) is a subunit of RNA Pol III transcription initiation factor TFIIIB that recruits Pol III to promoters by serving as a modular scaffold: its N-terminal TFIIB-homologous domain directs promoter opening and Pol III recruitment while its C-terminal domain provides the primary binding surfaces for TBP (through TBP dimerization dissociation and multi-site interaction), Bdp1 (via a 66-aa Brf1 segment engaging the Bdp1 SANT domain), and TFIIIC subunit Tfc4 (via multiple Brf1 peptide regions subject to Tfc4 autoinhibition); BRF1 is ubiquitinated by RNF12 (Lys27/Lys33-linked) and its protein stability is regulated by PKB-mediated phosphorylation at S92/S203 that promotes 14-3-3 binding and subcellular relocalization. In addition, a separate mammalian BRF1 protein (ZFP36L1/TIS11b, also called BRF-1) is an ARE-binding zinc-finger protein that recruits deadenylation, decapping, and exonucleolytic decay enzymes to ARE-containing mRNAs via two N- and C-terminal activation domains; its activity is negatively regulated by PKB (S92/S203 phosphorylation → 14-3-3 sequestration) and MK2 (S54/S92/S203), and positively or differentially regulated by PKA-mediated phosphorylation at S334, which enhances Dcp1a interaction while reducing Cnot1 interaction; it also delivers ARE-mRNAs to processing bodies downstream of polysome release and operates downstream of FGF/ERK signaling to control pluripotency.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"The BRF1 symbol in this corpus maps onto two distinct, internally coherent proteins, and the timeline cleanly separates them. The dominant entity is the RNA Polymerase III transcription factor BRF1 (TFIIIB90/hBRF, a TFIIB-related factor), a subunit of TFIIIB that recruits Pol III to its promoters [#0, #1]. BRF1 is built as a bipartite, modular scaffold: its N-terminal TFIIB-homologous half carries the principal transcription-directing function and inserts into the Pol III active-site cleft, with the cyclin-repeat subdomain contacting the Pol III subunit C34, while its C-terminal half assembles TFIIIB on DNA by providing the binding surfaces for TBP and Bdp1 [#5, #27]. BRF1 binds TBP through a bipartite, multi-site interface on the first TBP repeat that overlaps the surface used by Pol II factors, and it acts in concert with its TFIIB-homology domain to dissociate TBP dimers and dramatically stabilize the TBP\\u2013Bdp1 interaction [#2, #4, #14]; a 66-residue C-terminal segment serves as a two-sided adhesive that anchors Bdp1 via its conserved SANT domain [#18, #24]. BRF1 is recruited into the TFIIIB\\u2013TFIIIC\\u2013DNA complex through multiple peptide contacts with the TPR repeats of the TFIIIC subunit Tfc4, an interaction subject to Tfc4 autoinhibition that is relieved by conformational change [#12, #19]. Distinct human BRF1 splice variants confer promoter-type specificity, functioning at gene-internal tRNA-type promoters while a separate variant serves the U6-type promoter [#1, #8]. BRF1 expression and activity are heavily regulated: it is repressed by Maf1 and during p53-mediated arrest, ubiquitinated by RNF12, and transcriptionally driven by c-Jun, Sp1, and ER\\u03b1 to tune Pol III output [#9, #21, #32, #35, #31]. Biallelic activity-reducing BRF1 mutations cause cerebellar hypoplasia and intellectual disability, and Brf1 is essential for blastocyst viability and tissue homeostasis in mice [#29, #34]. The second, unrelated protein sharing the BRF1 name is the ARE-binding zinc-finger mRNA decay factor (ZFP36L1/TIS11b), which destabilizes ARE-containing mRNAs by recruiting deadenylation, decapping, and exonucleolytic decay enzymes through two activation domains and delivering transcripts to processing bodies [#10, #15, #22]; its decay activity is suppressed by PKB phosphorylation at S92/S203 driving 14-3-3 sequestration and by MK2, while PKA phosphorylation at S334 switches its association between Dcp1a and Cnot1, and it acts downstream of FGF/ERK to destabilize Nanog mRNA and limit pluripotency [#13, #17, #23, #30, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the molecular partners of BRF defined it as the bridging subunit of TFIIIB, answering how Pol III machinery is tethered to TBP and TFIIIC.\",\n      \"evidence\": \"Protein-protein binding assays of BRF fragments with TFIIIC, TBP and Pol III subunit C34 in yeast\",\n      \"pmids\": [\"7995525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the bipartite vs single-site nature of TBP binding\", \"No structural model of the contacts\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Purification of human BRF1 as a TBP-associated factor and its immunodepletion established that hBRF is required specifically for gene-internal (tRNA-type) but not TATA-type Pol III promoters.\",\n      \"evidence\": \"Biochemical purification, cloning, and immunodepletion followed by in vitro transcription from VAI and U6 promoters\",\n      \"pmids\": [\"8943358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain the molecular basis of promoter-type discrimination\", \"Identity of the U6-specific factor unresolved at this point\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Reconstitution from recombinant subunits showed BRF1 enhances the weak TBP\\u2013Bdp1 interaction >25-fold and that BRF1/Bdp1 occupy TBP surfaces shared with Pol II factors, defining BRF1 as the assembly nucleator of TFIIIB.\",\n      \"evidence\": \"Recombinant TFIIIB reconstitution, quantitative binding assays, and competition with TFIIA/TFIIB\",\n      \"pmids\": [\"8662956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise residues on TBP not yet mapped\", \"Stoichiometry and kinetics of assembly not fully defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Deletion analysis revealed functional complementarity between the BRF1 and Bdp1 subunits, showing the C-terminal half alone supports TBP/Bdp1 binding and complex assembly independent of the TFIIB-homology domain.\",\n      \"evidence\": \"N-terminal deletion series tested in TFIIIB-DNA assembly and TFIIIC-independent in vitro transcription\",\n      \"pmids\": [\"9271407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not assign specific transcription steps to the N-terminal domain\", \"Mechanism of subunit reciprocity left open\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Systematic mutagenesis of TBP and dissection of BRF1 fragments defined the modular architecture: TBP binding maps to a defined surface on the first repeat, assembly function to a C-proximal segment, and transcription-directing function to the N-terminal TFIIB-homology half.\",\n      \"evidence\": \"91 TBP surface mutants in gel-shift and transcription assays; BRF fragment library with footprinting and protein-DNA cross-linking\",\n      \"pmids\": [\"9488486\", \"9710642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of the contacts still lacking\", \"How the two halves cooperate during initiation not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstration that BRF1 partners with TRF1 rather than TBP in Drosophila, and that splice variants confer distinct promoter specificity in human, established context-dependent flexibility of BRF1-containing TFIIIB complexes.\",\n      \"evidence\": \"IP, immunodepletion/reconstitution, and polytene colocalization in fly; isoform cDNA isolation and promoter-specific in vitro transcription in human\",\n      \"pmids\": [\"10850489\", \"10921893\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of TBP-vs-TRF1 selection not defined\", \"Structural basis of promoter discrimination by isoforms unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Recombinant BRF1+TBP over the SNR6 TATA box sufficed to direct Ty3 integration, showing the minimal TFIIIB scaffold positions both Pol III initiation and retroviral integration machinery.\",\n      \"evidence\": \"In vitro integration assay with recombinant BRF1 and TBP in a TFIIIC-independent system\",\n      \"pmids\": [\"10882723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality beyond SNR6/TATA promoters not tested\", \"Physical link to integrase not mapped\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Linking human BRF1 (TAF3B2) protein stability to p53-mediated arrest established control of Pol III capacity through regulated BRF1 abundance.\",\n      \"evidence\": \"Complementation with in vitro transcription and protein stability analysis in p53-arrested cells\",\n      \"pmids\": [\"11283026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Degradation pathway not identified at this stage\", \"Direct vs indirect p53 effect unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of a distinct ARE-binding zinc-finger BRF1 (ZFP36L1) via genetic rescue established a completely separate protein that actively drives ARE-dependent mRNA decay and antagonizes PI3K-mediated stabilization.\",\n      \"evidence\": \"Retroviral cDNA rescue of decay-deficient cells, siRNA knockdown, and zinc-finger mutagenesis\",\n      \"pmids\": [\"12198173\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Decay enzymes recruited not yet identified\", \"Relationship to the Pol III BRF1 is purely nominal (name collision)\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery of the PCF1-1 gain-of-function mutation in Tfc4 showed BRF1 recruitment is gated by Tfc4 autoinhibition that can be relieved by conformational change.\",\n      \"evidence\": \"Site-directed mutagenesis, modeling, and affinity assays for BRF1 and Bdp1 with TFIIIC131 fragments\",\n      \"pmids\": [\"12167707\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"BRF1 does not bind at the mutation site \\u2014 conformational mechanism inferred not directly observed\", \"Structural state of relieved autoinhibition not solved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mapping overlapping BRF1 and Bdp1 binding sites on Tfc4 TPRs explained how the two TFIIIB subunits are competitively recruited onto the TFIIIC scaffold.\",\n      \"evidence\": \"Mutagenesis of Tfc4 TPR residues with assembly and direct binding assays plus multicopy suppression\",\n      \"pmids\": [\"12930823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Order of recruitment during assembly not fully resolved\", \"Structure of the Tfc4-BRF1 interface lacking\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"PKB phosphorylation of the ARE-decay BRF1 at S92 and demonstration of BRF1-driven TBP dimer dissociation in the transcription protein together defined active regulatory mechanisms in both namesake proteins.\",\n      \"evidence\": \"In vitro decay/kinase assays, S92A mutagenesis and 14-3-3 co-IP (ZFP36L1); in vitro TBP dimerization assays with domain fragments (Pol III BRF1)\",\n      \"pmids\": [\"15538381\", \"15190063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether a second phospho-site cooperates with S92 not yet known\", \"Structural basis of dimer dissociation not determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defining two activation domains on ARE-decay BRF1 that recruit deadenylation, decapping and exonucleolytic enzymes established it as a modular platform for assembling the mRNA decay machinery; engineering a BRF1-TBP triple fusion confirmed the modular bipartite TBP-interaction mode of the Pol III BRF1.\",\n      \"evidence\": \"Co-IP of decay enzymes, tethering and dominant-negative assays (ZFP36L1); triple-fusion reconstitution with footprinting and in vivo complementation (Pol III BRF1)\",\n      \"pmids\": [\"15687258\", \"16227432\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect contact of each decay enzyme not all resolved\", \"Bdp1-independent recruitment in fusion vs native context differences\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Residue-level mapping of the BRF1\\u2013Bdp1 interface (66-aa two-sided adhesive engaging the Bdp1 SANT domain) and demonstration of a second PKB site (S203) cooperating with S92 in the decay protein refined the molecular models for both proteins.\",\n      \"evidence\": \"Mutagenesis/cross-linking of BRF1-Bdp1 segments (Pol III); kinase, mutagenesis, fractionation and KO-cell stability assays for S92/S203 14-3-3 sequestration (ZFP36L1); genome-wide ChIP of TRF1/BRF in fly\",\n      \"pmids\": [\"16551611\", \"17030608\", \"17170711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the BRF1-Bdp1 interface not yet at NMR resolution here\", \"Genome-wide BRF1 targets in mammals not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placing Maf1 repression directly through BRF1/Brf2 and showing ARE-decay BRF1 delivers mRNAs to processing bodies positioned both proteins within their respective regulatory pathways.\",\n      \"evidence\": \"Pol III luciferase reporter epistasis (Maf1); siRNA depletion, dominant-negative, tethering and live imaging of ARE-mRNAs in PBs\",\n      \"pmids\": [\"17505538\", \"17369404\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Maf1-BRF1 contact not biochemically mapped here\", \"PB localization step relative to decay completion not fully ordered\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"MK2 phosphorylation of ARE-decay BRF1 at S54/S92/S203 inhibits decay downstream of RNA binding and enzyme recruitment, distinguishing the regulatory step from substrate engagement.\",\n      \"evidence\": \"In vitro kinase, site-directed mutagenesis, decay assays, ARE binding and decay-enzyme co-IP\",\n      \"pmids\": [\"18326031\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the C-terminal MK2 site not determined\", \"Mechanism downstream of recruitment that blocks decay unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"NMR mapping localized the principal BRF1 anchorage on the convex SANT-domain surface of Bdp1 (residues 470\\u2013495 of BRF1), giving a residue-resolution model of the TFIIIB core interface.\",\n      \"evidence\": \"NMR chemical shift perturbation with minimal functional Brf1/Bdp1 segments\",\n      \"pmids\": [\"19086269\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length complex structure not solved\", \"DNA-bound conformation of the interface not captured\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying c-Jun/JNK1 induction of BRF1 and TBP expression connected Pol III transcriptional capacity to stress and ethanol signaling at the level of TFIIIB abundance.\",\n      \"evidence\": \"ChIP of c-Jun at the BRF1 promoter, reporters, siRNA, and an in vivo mouse alcohol model\",\n      \"pmids\": [\"21106530\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct enzymatic link from JNK1 to BRF1 promoter not isolated\", \"Physiological consequence of elevated Pol III output not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstration that the ARE-decay BRF1 (Tis11b) represses Dll4 by interfering with 3'-end cleavage/polyadenylation extended its repertoire beyond classical decay into co-transcriptional/processing control.\",\n      \"evidence\": \"siRNA, RNA-IP of endogenous Dll4 mRNA, 3'-UTR reporters and poly(A) site usage analysis\",\n      \"pmids\": [\"21832157\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality across other targets not established\", \"Mechanistic link to the cleavage/polyadenylation machinery not mapped\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Site-specific cross-linking in the native preinitiation complex mapped the full BRF1 interaction network, showing the N-terminal domain behaves like TFIIB in the Pol III cleft and contacts C34, while the C-terminal domain holds TBP and Bdp1 on the promoter.\",\n      \"evidence\": \"Non-natural amino acid cross-linking and hydroxyl radical probing in the Pol III PIC\",\n      \"pmids\": [\"24277937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamic transitions during open-complex formation not captured\", \"Quantitative contributions of each contact to initiation not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Positioning ARE-decay BRF1 downstream of FGF/ERK to destabilize Nanog mRNA established a signaling-to-mRNA-decay axis controlling pluripotency and lineage commitment.\",\n      \"evidence\": \"FGF/ERK manipulation with Brf1 gain/loss-of-function and mRNA stability/differentiation assays in mESCs\",\n      \"pmids\": [\"24733888\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect ERK control of Brf1 not fully separated\", \"Full target set beyond Nanog not catalogued\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying biallelic activity-reducing BRF1 mutations that lower tRNA-gene occupancy and Pol III transcription, with cross-species recapitulation, established BRF1 loss-of-function as the cause of cerebellar hypoplasia and intellectual disability.\",\n      \"evidence\": \"Exome sequencing, yeast complementation with disease alleles, ChIP occupancy, in vitro Pol III transcription, and zebrafish CRISPR/morpholino\",\n      \"pmids\": [\"25561519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific basis of the neurodevelopmental phenotype not resolved\", \"Which Pol III transcripts drive pathology not pinpointed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showing PKA phosphorylation of ARE-decay BRF1 at S334 switches its association between Dcp1a and Cnot1 revealed phosphorylation-driven routing between distinct decay pathways and stabilization of the protein.\",\n      \"evidence\": \"Kinase assays, phosphomimetic mutagenesis, half-life measurement and co-IP with Dcp1a and Cnot1\",\n      \"pmids\": [\"27708140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals driving S334 phosphorylation in vivo not defined\", \"Net effect on specific endogenous targets not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying RNF12-mediated K27/K33-linked ubiquitination of Pol III BRF1 and the Rpc82 WH3 contact within the PIC added a degradative regulatory input and a new Pol III subunit contact to the transcription-factor BRF1.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination with linkage analysis and Pol III/proliferation assays (RNF12); site-specific photo-crosslinking with functional assays (Rpc82)\",\n      \"pmids\": [\"30413534\", \"29177422\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether K27/K33 chains target BRF1 for degradation or signaling unresolved\", \"Functional consequence of the Rpc82 WH3-BRF1 contact for initiation not quantified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Conditional and constitutive Brf1 knockout in mice established that the Pol III transcription factor is essential for blastocyst viability and adult tissue homeostasis, with loss inducing apoptosis rescuable by re-expression.\",\n      \"evidence\": \"Conditional KO mouse models, genetic rescue, histology and apoptosis assays\",\n      \"pmids\": [\"30858608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific transcript dependencies not defined\", \"Threshold of Pol III activity for survival not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing Sp1 and ER\\u03b1 drive BRF1 expression and promoter occupancy connected upstream Pol II transcription factors to the regulation of Pol III capacity through BRF1 abundance.\",\n      \"evidence\": \"Reporter assays, ChIP of Sp1/TBP/TFIIA\\u03b1/p300 at the BRF1 promoter, and knockdown/overexpression (Sp1); co-IP, colocalization and ChIP with siRNA/tamoxifen (ER\\u03b1)\",\n      \"pmids\": [\"32115405\", \"28972307\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct functional consequence of ER\\u03b1-BRF1 physical interaction beyond expression unclear\", \"Crosstalk between Sp1- and ER\\u03b1-driven control not integrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the bipartite BRF1 contacts are dynamically remodeled during Pol III open-complex formation and promoter escape, and the full in vivo target spectrum and tissue-specific essential transcripts underlying BRF1-related disease are uncharacterized.\",\n      \"evidence\": \"No discovery in the corpus captures the dynamic transitions of BRF1 within an actively initiating Pol III complex or the disease-relevant target set\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM/structural snapshot of dynamic initiation states in the corpus\", \"Tissue-specific Pol III transcript dependencies driving disease undefined\", \"Integration of the two namesake proteins (if any biological overlap) not addressed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 5, 8, 27]},\n      {\"term_id\": \"GO:0140223\", \"supporting_discovery_ids\": [1, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 27]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 18, 24]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [10, 15, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 31]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [6, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 5, 8, 27]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [10, 15, 22]}\n    ],\n    \"complexes\": [\n      \"TFIIIB\",\n      \"Pol III preinitiation complex\"\n    ],\n    \"partners\": [\n      \"TBP\",\n      \"Bdp1\",\n      \"Tfc4\",\n      \"C34\",\n      \"RNF12\",\n      \"ESR1\",\n      \"Dcp1a\",\n      \"Cnot1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}